Medical Research Articles Published in June 2012

With a Free Docphin Account, you create a custom list of medical research journal sources that are easy to navigate, search our extensive databse of articles, save and organize your articles into folders, set up alerts to be notificed of research articles that match your interests ... and much more.

Login or Register
06/04/2012
Abstract 5722: Retention of the radiosensitizing effect of gemcitabine and its main metabolite dFdU under reduced oxygen conditions is not influenced by HIF-1 functionality Cancer Research
06/04/2012
Abstract 5721: Garcinol, a histone acetyltransferase inhibitor, radiosensitizes cancer cells by inhibiting non-homologous end joining Cancer Research
06/04/2012
Abstract 5719: Improvement of radiotherapy for glioblastoma by co-targeting PI3K and HSP90 Cancer Research
06/04/2012
Abstract 5718: Implementation of {mu}-Image Guided Radio-Therapy in the treatment of experimental glioma mouse models: Assessment of the potential of agents that interfere with DNA repair Cancer Research
06/04/2012
Abstract 5717: The Poly (ADP-Ribose) Polymerase-1 Inhibitor, AZD2281, enhances radiation response of breast cancer cells by inhibiting DNA repair Cancer Research
06/04/2012
Abstract 5716: Interference with repair of sub-lethal radiation damage by ABT-888, an inhibitor of poly(ADP-ribose) polymerase (PARP), and theobromine Cancer Research
06/04/2012
Abstract 5715: Modulation of Radiation Response after TGF{beta} signaling Blockade in Non-small Cell Lung Cancer (NSCLC) Cell Carcinomas Cancer Research
06/04/2012
Abstract 5714: Combination of glucagon-like-peptide-1 (GLP-1) receptor targeted therapy with anti-angiogenic compounds in a mouse model of neuroendocrine tumors Cancer Research
06/04/2012
Abstract 5713: Significant systemic therapeutic effects of high-LET immunoradiation by 212Pb-Trastuzumab against prostatic tumors of androgen-independent human prostate cancer in mice Cancer Research
06/04/2012
Abstract 5712: Alpharadin (Radium-223 chloride) completely prevents tumor growth in bone and increases survival in a mouse model of breast cancer bone metastases in preventive and micro-metastatic settings Cancer Research
06/04/2012
Abstract 5711: Applying new light to the detection and treatment of brain cancers using targeted photodynamic therapy Cancer Research
06/04/2012
Abstract 5710: Effective siRNA delivery through specific targeting of tumor Cancer Research
06/04/2012
Abstract 5709: Formulation development and evaluation of nanostructured lipid carriers for topical delivery of honokiol Cancer Research
06/04/2012
Abstract 5708: Interstitial protein delivery evaluated in multicellular layers model Cancer Research
06/04/2012
Abstract 5707: The EPR effects of Elastin-like polypeptide of differnt molecular sizes in animal tumor models Cancer Research
06/04/2012
Abstract 5706: Engineering of trans kingdom RNAi (tkRNAi) against gastrointestinal polyps Cancer Research
06/04/2012
Abstract 5704: Curcumin-folate conjugate for increased bioavailability and targeted delivery of curcumin to cancer cells Cancer Research
06/04/2012
Abstract 5703: Efficient targeted delivery of protein toxins using self-manufacturing nanoparticles (minicells) derived from bacteria Cancer Research
06/04/2012
Abstract 5702: NanoOxaza, pre-activated oxazaphosphorines prodrugs designed for drug delivery strategy with wide anticancer activity Cancer Research
06/04/2012
Abstract 5701: Targeting KRAS lung cancer in vivo by pulmonary surfactant-mediated gene transfer Cancer Research
06/04/2012
Abstract 5700: Preparation and evaluation of glycosylated paclitaxel loaded in tastuzumab-immunoliposome Cancer Research
06/04/2012
Abstract 5699: Mesenchymal stem cells (MSCs) as a selective delivery vehicle for a PSA-activated protoxin for advanced prostate cancer Cancer Research
06/04/2012
Abstract 5698: Concurrent delivery of paclitaxel and 17-AAG via micellar nanocarriers Cancer Research
06/04/2012
Abstract 5697: Multistage vectored nanotherapeutics of breast cancer lung metastasis Cancer Research
06/04/2012
Abstract 5696: Evaluating determinants for enhanced activity of MM-398/PEP02; a novel nanotherapeutic encapsulation of irinotecan (CPT-11) Cancer Research
06/04/2012
Abstract 5695: PLGA microspheres for MRI-guided localized transcatheter delivery of sorafenib: development and preclinical feasibility studies Cancer Research
06/04/2012
Abstract 5694: Targeted photothermal-chemotherapy with doxorubicin-loaded hollow gold nanospheres directed at EphB4 receptors Cancer Research
06/04/2012
Abstract 5693: Guided intracellular drug delivery and release with plasmonic nanobubbles in drug-resistant cancer cells Cancer Research
06/04/2012
Abstract 5692: Targeted inhibition of cancer stem cells by self-assembled miRNA-nanovectors Cancer Research
06/04/2012
Abstract 5691: Novel site-specific antibody drug conjugates based on novel amino acid incorporation technology have improved pharmaceutical properties over conventional antibody drug conjugates Cancer Research
06/04/2012
Abstract 5690: Validating sigma-2 receptor ligand as a novel tumor-targeted drug delivery agent for treating ovarian cancer Cancer Research
06/04/2012
Abstract 5689: Anti-E2F-1 PEGylated liposomal encapsulated peptide regresses human small cell lung cancer & lymphoma xenografts Cancer Research
06/04/2012
Abstract 5688: Multifunctional gold nanoparticles linked with aptamers and fluorophores for breast cancer imaging and therapy Cancer Research
06/04/2012
Abstract 5687: Development of glutathione pegylated liposomal doxorubicin (2B3-101) for the treatment of brain cancer Cancer Research
06/04/2012
Abstract 5686: Engineering multifunctional nanoparticles to selectively target multiple myeloma cells and overcome cell adhesion-mediated drug resistance Cancer Research
06/04/2012
Abstract 5685: Effects of sonic Hedgehog inhibitor combined with nanoparticulate drug delivery on vascular permeability and efficacy in a pancreatic cancer model Cancer Research
06/04/2012
Abstract 5684: Sustained gene silencing by liposomal siRNA incorporated mesoporous silicon particles Cancer Research
06/04/2012
Abstract 5683: Design and characterization of novel targeted nanoparticle delivery systems for cancer chemotherapy Cancer Research
06/04/2012
Abstract 5682: Modeling the pharmacological importance of endoxifen for the treatment of ER-positive breast cancer in premenopausal patients Cancer Research
06/04/2012
Abstract 5681: A high throughput soft agar assay on a panel of 60 tumor cell lines to study compounds for potential anti-oncogenic properties Cancer Research
06/04/2012
Abstract 5680: Bortezomib-induced quiescence of multiple myeloma cells is associated with changes in the expression of p21(CIP/KIP) and the H3K27-methyltransferase EZH2 Cancer Research
06/04/2012
Abstract 5679: Characterization in vivo of two different molecular mechanisms involved in the development of bortezomib-induced peripheral neuropathy Cancer Research
06/04/2012
Abstract 5678: Functional analysis of tyrosyl-DNA phosphodiesterase I catalytic mutants Cancer Research
06/04/2012
Abstract 5677: A comparative study of the interaction of the maytansinoid, DM1-Me, vinblastine, and taxol with human cells Cancer Research
06/04/2012
Abstract 5676: Effects of resveratrol on paclitaxel-sensitive and -resistant triple negative breast cancer cells Cancer Research
06/04/2012
Abstract 5675: Potential use of proteosome pathway inhibitor (bortezomib) in combination with anthracyclines to treat multiple myeloma and pancreatic cancer Cancer Research
06/04/2012
Abstract 5674: Effect of clofarabine on apoptosis and DNA synthesis in human breast cancer Cancer Research
06/04/2012
Abstract 5673: Mechanisms responsible for the antitumor effect of metronomic chemotherapy with cyclophosphamide (Cy) and doxorubicin (Dox) in murine tumor models of mammary adenocarcinoma Cancer Research
06/04/2012
Abstract 5672: Mibefradil increases paclitaxel's effect on MCF-7 cell proliferation in vitro and in vivo Cancer Research
06/04/2012
Abstract 5671: Differential roles of caveolin-1 variants in cell death in breast cancer Cancer Research
06/04/2012
Abstract 5670: Phospho-PEA-15 sensitizes ovarian cancer cells to paclitaxel by impairing the microtubule-destabilizing effect of SCLIP Cancer Research
06/04/2012
Abstract 5669: Mechanisms of activity and drug resistance with proteasome inhibitors in multiple myeloma: Comparison of bortezomib and the investigational drug MLN9708 Cancer Research
06/04/2012
Abstract 5668: Vorinostat exposure results in differential sensitivity and nuclear structure normalization in an in vitro model of esophageal adenocarcinoma progression Cancer Research
06/04/2012
Abstract 5667: Mechanism-based combinations of agents impacting the homologous recombination and nucleotide excision repair pathways Cancer Research
06/04/2012
Abstract 5666: DNA repair defects enhance tumor cell sensitivity to sapacitabine Cancer Research
06/04/2012
Abstract 5665: Multiplexing markers of response to sorafenib/mapatumumab combination therapy in hepatocellular carcinoma circulating tumor cells Cancer Research
06/04/2012
Abstract 5664: Molecular effects of doxycycline treatment on pterygium as revealed by massive transcriptome sequencing Cancer Research
06/04/2012
Abstract 5662: The development of SCLC specific nanoparticle-mediated p53 gene therapy Cancer Research
06/04/2012
Abstract 5661: Pharmaceutically controlled replication of adenoviruses in mesenchymal stem cell-based cell carriers improves oncolytic virotherapy for advanced human renal cell carcinoma Cancer Research
06/04/2012
Abstract 5660: Vaccinia virus GLV-1h153 in combination with 131I-iodine shows increased efficiency in treating triple-negative breast cancer in vivo Cancer Research
06/04/2012
Abstract 5659: In vivo efficiency and biodistribution of TNF-alpha expressing small-sized vector DNA after intratumoral nonviral jet-injection Cancer Research
06/04/2012
Abstract 5658: Engineered Salmonella effectively produce and preferentially deliver bacterial cytotoxins to solid tumors Cancer Research
06/04/2012
Abstract 5657: uPAR-mediated endothelial targeting facilitates endothelial to tumor cell transfer of oncolytic measles virus: In vitro and in vivo studies. Cancer Research
06/04/2012
Abstract 5656: Preclinical evaluation of cytotoxic effect of photosensitive fluorescent protein in human cancer cells Cancer Research
06/04/2012
Abstract 5655: Infectivity selective oncolytic adenovirus for pancreatic cancer by redesigning the AB-loop via adenovirus library screening Cancer Research
06/04/2012
Abstract 5654: Novel tissue-targeted virogeneimaging system for squamous cell carcinoma therapy expressing cell cycle regulator cdk2ap1 Cancer Research
06/04/2012
Abstract 5653: A novel cationic peptide nanoparticle-based gene therapy with angiotensin II type 2 receptor gene significantly attenuates growth of lung adenocarcinoma xenografts in mouse model Cancer Research
06/04/2012
Abstract 5651: p53-mediated apoptotic signaling overcomes the resistance to oncolytic adenovirus in human osteosarcoma cells Cancer Research
06/04/2012
Abstract 5650: Targeting siRNA to tumors and their stroma as a dual anticancer and anti-angiogenic therapy Cancer Research
06/04/2012
Abstract 5649: Quorum-sensing salmonella selectively trigger protein expression within tumor models Cancer Research
06/04/2012
Abstract 5648: Low MEOX2 expression is a feature of stem-like Rat BTUC glioma cell line and contributes to its profound resistance to oncolytic herpes virus infection Cancer Research
06/04/2012
Abstract 5647: Marked sensitivity to mRNA targeting by LNA antisense in tumor cells without a delivery system: Lessons learned and potential translation to the clinic Cancer Research
06/04/2012
Abstract 5646: Allele-specific shRNA to Nanog family members inhibits 3-D growth of colorectal carcinoma through the intrinsic apoptotic pathway Cancer Research
06/04/2012
Abstract 5644: Targeted nanocarriers of siRNA for the treatment of cancer Cancer Research
06/04/2012
Abstract 5643A: Pleurotus pulmonarius extract suppresses liver cancer development and progression through VEGF-mediated autocrine regulation of PI3K/AKT pathway Cancer Research
06/04/2012
Abstract 5643: CRLX301, a novel tumor-targeted taxane nanopharmaceutical Cancer Research
06/04/2012
Abstract 5642: Wound-healing drainages contribute to triple negative breast cancers aggressiveness Cancer Research
06/04/2012
Abstract 5640: Preclinical of assessment of oxidative stress and apoptotic mechanisms of garlic extract in the prevention of acute promyelocytic leukemia Cancer Research
06/04/2012
Abstract 5639: Pro-drug forms of triterpenes with anticancer activity Cancer Research
06/04/2012
Abstract 5638: New synthetic analogs of migrastatin as potent cell migration inhibitors to block overall metastasis in lung cancer and colorectal carcinoma Cancer Research
06/04/2012
Abstract 5637: Plumbagin, a plant derived napthoquinone, inhibits the metastatic growth of human prostate cancer PC-3M luciferase cells in an orthotropic xenograft mouse model Cancer Research
06/04/2012
Abstract 5636: Preclinical data of a microRNA-based therapy for hepatocellular carcinoma Cancer Research
06/04/2012
Abstract 5635: Pegylated recombinant human hyaluronidase PH20 (PEGPH20) enhances Nab-Paclitaxel efficacy in BxPC-3 human pancreatic cancer xenografts Cancer Research
06/04/2012
Abstract 5633: BreastDefend suppresses growth and breast-to-lung cancer metastasis in an orthotopic model of human breast cancer Cancer Research
06/04/2012
Abstract 5632: Immunoprotected, microencapsulated bacterial cytosine deaminase mediated conversion of 5-fluorocytosine to 5-fluorouracil Cancer Research
06/04/2012
Abstract 5631: The effect of pomegranate extract dose on prostate cancer growth in a carbohydrate restricted mouse xenograft model Cancer Research
06/04/2012
Abstract 5630: Nanotherapeutic silencing of HuR: Targeting a tumor-promoting response in ovarian cancer Cancer Research
06/04/2012
Abstract 5629: Arginine depravation therapy with arginine deiminase and autophagy inhibition is a novel therapeutic approach for the treatment of metastatic sarcomas that lack argininosuccinate synthetase expression Cancer Research
06/04/2012
Abstract 5628: Novel cell permeable peptide inhibitors of PELP1 oncogenic functions Cancer Research
06/04/2012
Abstract 5627: Tumorigenesis and prognostic role of hepatoma-derived growth factor in human gliomas Cancer Research
06/04/2012
Abstract 5626: FKBP51 is a crucial modulator of melanoma plasticity and promising molecular target for preventing melanoma metastasis Cancer Research
06/04/2012
Abstract 5624: HMG box-containing protein 1 (HBP1) participates in the antitumor effect of N-acetylcysteine (NAC) in invasive oral cancer Cancer Research
06/04/2012
Abstract 5623: Eliminating pancreatic cancer metastases through inhibition of hedgehog and RAS signaling Cancer Research
06/04/2012
Abstract 5622: Effect of novel RhoC inhibitor on breast cancer progression and metastasis in vivo Cancer Research
06/04/2012
Abstract 5621: MicroRNA 203 modulates glioma cell migration and invasion by targeting ROBO1 Cancer Research
06/04/2012
Abstract 5620: Therapeutic targeting of glypican-3 using TGF-{beta}2 as a novel treatment approach for HCC Cancer Research
06/04/2012
Abstract 5619: Drugging the "undrugable" DNA-binding domain of STAT3 for inhibition of cancer cell migration and invasion Cancer Research
06/04/2012
Abstract 5618: Tumor suppressor genes? The status of genes PAX 5 in primary and secondary gliomas and glioblastoma multiforme tumors Cancer Research
06/04/2012
Abstract 5616: Mutant PEA-15 inhibits in vitro and in vivo tumorigenesis in ovarian cancer by inhibiting beta-catenin Cancer Research
06/04/2012
Abstract 5615: Combination therapy for chronic myelogenous leukemia: Targeting the BCR-ABL coiled-coil domain and other pathways for synthetic lethality Cancer Research
06/04/2012
Abstract 5614: Tandutinib (MLN518/CT53518) targeted to stem-like cells by inhibiting the function of ATP-binding cassette subfamily G member 2 Cancer Research
06/04/2012
Abstract 5613: A specific isoform of Gli1 binds the Gli-binding site of the c-jun and c-fos promoters Cancer Research
06/04/2012
Abstract 5612: The PI3K/Akt inhibitor LY294002 reverses BCRP/ABCG2-mediated drug resistance without BCRP translocation Cancer Research
06/04/2012
Abstract 5611: A synthetic lethality combination with chloroquine and rapamycin on chemosensitization Cancer Research
06/04/2012
Abstract 5610: Activation of Ras/PI3K/ERK pathway induces c-Myc stabilization to upregulate argininosuccinate synthetase, leading to arginine deiminase resistance in melanoma cells Cancer Research
06/04/2012
Abstract 5609: Mechanisms of acquired resistance to selective PI3K inhibitors in breast cancer cell lines Cancer Research
06/04/2012
Abstract 5608: Functional genetic screens to find modulators of sensitivity to inhibitors of the PI3K/mTOR pathway Cancer Research
06/04/2012
Abstract 5607: TLE4 is a key modulator of resistance to mTOR pathway specific inhibition in glioblastoma Cancer Research
06/04/2012
Abstract 5606: Hedgehog pathway is a novel therapeutic target in tamoxifen resistant breast cancer that protects from autophagic cell death and is aberrantly activated by PI3K/AKT signaling Cancer Research
06/04/2012
Abstract 5605: LKB1 and KRAS mutations predict resistance to PI3K/Akt inhibitors in non-small cell lung cancer Cancer Research
06/04/2012
Abstract 5604: Targeting survivin (BIRC5) with YM155 for the treatment of head and neck squamous cell carcinoma Cancer Research
06/04/2012
Abstract 5601: Overcoming acquired resistance to BRAF inhibitors in melanoma with the HSP90 inhibitor ganetespib Cancer Research
06/04/2012
Abstract 5599: Allosteric regulation of Abl and Bcr-Abl kinases by enhanced SH3:linker interaction Cancer Research
06/04/2012
Abstract 5598: Interaction between BRAF inhibitor PLX-4720 and CDK inhibitors can sensitize melanoma cells with BRAF V600E mutation Cancer Research
06/04/2012
Abstract 5597: Modulating therapeutic effects of c-Src inhibitor via estrogen receptor and HER2 in breast cancer cell lines Cancer Research
06/04/2012
Abstract 5596: Altered efficacy of tyrosine kinase inhibitors in chronic myeloid leukemia cells expressing wild type or polymorphic ABCG2 Cancer Research
06/04/2012
Abstract 5595: ALK mutant-driven cell lines develop crizotinib resistance by secondary mutations and ALK-independent means Cancer Research
06/04/2012
Abstract 5594: ALK-driven lung cancer: Potential therapeutic strategies for treatment and prevention of drug resistance Cancer Research
06/04/2012
Abstract 5593: Mechanisms of acquired crizotinib resistance in ALK-rearranged lung cancers Cancer Research
06/04/2012
Abstract 5592: Modeling the evolution of resistance to RAF inhibitors in clinically relevant melanoma models Cancer Research
06/04/2012
Abstract 5591: A phase I study of bavituximab and sorafenib in patients with advanced hepatocellular carcinoma (HCC) Cancer Research
06/04/2012
Abstract 5590: A phase I/II study of decitabine with pegylated interferon {alpha}-2b in advanced melanoma: clinical results and impact on DNA methylation and immune modulation Cancer Research
06/04/2012
Abstract 5588: A phase I, open label, dose escalation study of an oral mammalian target of rapamycin inhibitor INK128 administered once daily in patients with advanced malignancies Cancer Research
06/04/2012
Abstract 5587: Phase I study of PM00104 in combination with carboplatin in patients (pts) with advanced solid tumors Cancer Research
06/04/2012
Abstract 5586: Phase I study of PARP inhibitor ABT-888 and carboplatin with novel imaging in metastatic breast cancer (MBC) (NCI-8609) Cancer Research
06/04/2012
Abstract 5585: Phase I clinical trial of continuous infusion of tyroserleutide in patients with advanced hepatocellular carcinoma Cancer Research
06/04/2012
Abstract 5576: pmTOR and vascular endothelial growth factor receptor (VEGFR)-2 expressions in gastroenteropancreatic neuroendocrine tumors (GEP-NETs) Cancer Research
06/04/2012
Abstract 5575: Promoter methylation of SNFP4 gene as potential diagnosis biomarker in cervical cancer: Exploratory study phase I Cancer Research
06/04/2012
Abstract 5574: ZNF516 and FKBP6 promoter hypermethylation as a potential companion diagnostic panel for HPV-positive and inconclusive-Pap women Cancer Research
06/04/2012
Abstract 5573: Nuclear IGF-1R expression as a prognostic factor in cervical cancer patients Cancer Research
06/04/2012
Abstract 5572: Prognostic significance of TS, TK, OPRT and DPD activities in renal cell carcinoma Cancer Research
06/04/2012
Abstract 5571: Inflammatory response as a novel prognostic parameter in patients with metastatic renal cell carcinoma treated with pazopanib Cancer Research
06/04/2012
Abstract 5570: Prognostic biomarkers in patients with clear cell renal cell carcinoma (ccRCC) Cancer Research
06/04/2012
Abstract 5569: DNA methylation status of MLH1, p16, SOCS1, ER and CDH1 in Puerto Rican patients with acute myeloid leukemia Cancer Research
06/04/2012
Abstract 5568: Constitutively activation of STAT3 is a prognostic factor in activated B-cell subtype of diffuse large B-cell lymphoma Cancer Research
06/04/2012
Abstract 5566: Elevated CXCR4 expression is clinically correlated with advanced stage neuroblastoma: examination of its role as a possible therapeutic target Cancer Research
06/04/2012
Abstract 5565: Circulating tumor cells in the peripheral blood and cerebrospinal fluid of patients with central nervous system metastases Cancer Research
06/04/2012
Abstract 5564: Molecular profiling of RTOG 9813: Optimization of a pilot study to identify novel molecular biomarkers for anaplastic astrocytomas Cancer Research
06/04/2012
Abstract 5563: Comparative studies of TIMP-1 immunohistochemistry, TIMP-1 FISH analysis and plasma TIMP-1 in glioblastoma patients Cancer Research
06/04/2012
Abstract 5562: Utility of circulating biomarkers as outcome predictors in metastatic colorectal cancer and recurrent glioblastoma multiforme patients treated with bevacizumab/sorafenib Cancer Research
06/04/2012
Abstract 5561: Radiogenomic analysis indicates MR images are potentially predictive of EGFR mutation status in glioblastoma multiforme Cancer Research
06/04/2012
Abstract 5560: PROX1 expression and function in malignant gliomas Cancer Research
06/04/2012
Abstract 5559: Detection of IDH1 mutation in the plasma of glioma patients Cancer Research
06/04/2012
Abstract 5558: Interplay between BRAF, p16, p53, and MIB1 in pediatric low grade gliomas Cancer Research
06/04/2012
Abstract 5557: Mutation analysis of melanoma tumor samples from ECOG 2603 clinical trial Cancer Research
06/04/2012
Abstract 5556: Evaluation of maspin expression in primary tumors and metastasis of melanoma patients: Evidences for prognostic significance Cancer Research
06/04/2012
Abstract 5555: Metastatic melanoma associated genes identified using the human tumor metastasis RT2 profiler PCR array Cancer Research
06/04/2012
Abstract 5553: Real-time imaging of {alpha}v integrin-GFP expression in osteosarcoma cells trafficking in blood vessels of nude mice Cancer Research
06/04/2012
Abstract 5552: Macrophages increase brain metastasis in a chick embryo model Cancer Research
06/04/2012
Abstract 5551: Somatic mutations in KRAS, BRAF and PIK3CA genes in Chilean patients with sporadic colorectal cancer: Correlation with clinical and histological features Cancer Research
06/04/2012
Abstract 5550: Ingenol mebutate induces an early and inflammatory wound healing response in a human in vitro 3-D skin model Cancer Research
06/04/2012
Abstract 5549: Normal bronchial epithelial cells (NBEC) sample RNA quality characteristics that will yield reliable measurement of lung cancer risk test Cancer Research
06/04/2012
Abstract 5548: High copy number of the MET gene predicts resistance to EGFR-TKI in non-small cell lung cancer patients. Cancer Research
06/04/2012
Abstract 5547: Oral delivery of tumor-targeting Salmonella typhimurium A1-R is effective therapeutically Cancer Research
06/04/2012
Abstract 5546: UVC irradiation inhibits superficial tumor growth in the brain of nude mice Cancer Research
06/04/2012
Abstract 5545: MethyMeter(R) - A quantitative, bisulfite-free DNA methylation assay for improved clinical diagnostic and prognostic analysis of glioma biomarkers in FFPE tumor samples Cancer Research
06/04/2012
Abstract 5543: Hetmap: Evaluating tumor heterogeneity in immunohistochemistry-stained breast cancer tissue Cancer Research
06/04/2012
Abstract 5542: Gene expression and genomic DNA stabilization in whole blood stored at room temperature Cancer Research
06/04/2012
Abstract 5541: Molecular diagnostic tests to augment cytomorphologic diagnosis of lung cancer Cancer Research
06/04/2012
Abstract 5540: Non malignant breast cancer tissue identification scoring system Cancer Research
06/04/2012
Abstract 5539: Snail expression is associated with epithelial to mesenchymal transition and a poor prognosis in malignant pleural mesotheliomas Cancer Research
06/04/2012
Abstract 5538: Development of RNA quality control methods to improve BCR-ABL measurement in whole blood samples Cancer Research
06/04/2012
Abstract 5537: Quantitative multiplexed SRM analysis of oncogenic receptors in FFPE colorectal carcinoma tissue Cancer Research
06/04/2012
Abstract 5536: TP53 and MED12 mutations in uterine smooth muscle tumors Cancer Research
06/04/2012
Abstract 5535: Availability of a newly designed technique, triple-combination array analysis: Identification of estrogen receptor 1 gene in hepatocellular carcinoma using this method Cancer Research
06/04/2012
Abstract 5534: Building the organization framework for biopsy-driven translational research: The Quebec Clinical Research Organization in Cancer (Q-CROC) experience Cancer Research
06/04/2012
Abstract 5533: Imaging stromal recruitment during liver metastasis formation in the GFP-MUP-uPA mouse Cancer Research
06/04/2012
Abstract 5532: Anti-cancer activities of tea epigallocatechin-3-gallate in breast cancer patients under radiotherapy Cancer Research
06/04/2012
Abstract 5531: Lumican as a novel differential diagnostic maker for Bowen's disease and actinic keratosis Cancer Research
06/04/2012
Abstract 5530: Fluorescence laparoscopy improves metastatic detection in both early and advanced colon cancer Cancer Research
06/04/2012
Abstract 5529: Fluorescence-guided navigation surgery for resection of human glioma in an orthotopic model in nude mice Cancer Research
06/04/2012
Abstract 5528: Setting the clock: Tumor TK1 is a prognostic marker for disease recurrence Cancer Research
06/04/2012
Abstract 5527: Overexpression of protein phosphatase 4 is associated with poor prognosis in patients with pancreatic ductal adenocarcinoma Cancer Research
06/04/2012
Abstract 5526: Lymphangiogenesis in regional lymph nodes is an independent prognostic marker in rectal cancer patients after neoadjuvant treatment Cancer Research
06/04/2012
Abstract 5525: Influence of total dissected lymph node number on metastatic detection rate and survival in 10,382 esophageal cancer patients from the high incidence area for esophageal cancer in northern China Cancer Research
06/04/2012
Abstract 5524: Prostate cancer risk assessment model (PCRAM): a scoring model based on the Swedish Family-Cancer Database Cancer Research
06/04/2012
Abstract 5523: Cost effectiveness of implementing a screening and treatment program for hepatitis C virus infection in Egypt Cancer Research
06/04/2012
Abstract 5522: Analysis of recruitment of non small cell lung cancer patients into clinical trials Cancer Research
06/04/2012
Abstract 5521: Development of a web-based patient registry and DNA repository for pediatric cancer research in individuals with neurofibromatosis type 1 Cancer Research
06/04/2012
Abstract 5520: How widely shared are institutional human biospecimen resources: a comparison of an institutional-level response versus a PI-level response Cancer Research
06/04/2012
Abstract 5519: Prevalence of three types of cancers in southern part of Nigeria Cancer Research
06/04/2012
Abstract 5518: Clinicopathologic associations with colorectal cancer molecular pathways in a cohort study of older women Cancer Research
06/04/2012
Abstract 5517: Pre-existing medical conditions and risk of breast cancer in Korea: A hospital based case-control study Cancer Research
06/04/2012
Abstract 5516: Race, age and advanced stage colorectal cancer survival Cancer Research
06/04/2012
Abstract 5515: An investigation of risk factors for renal cell carcinoma by histologic subtype in two case-control studies Cancer Research
06/04/2012
Abstract 5514: Comorbidities are associated with breast cancer in African-American and Hispanic women Cancer Research
06/04/2012
Abstract 5513: Treatment and mortality in men with localized prostate cancer: A population-based study in California Cancer Research
06/04/2012
Abstract 5512: Increased incidence of adult cancers in relatives of childhood cancer patients and difference in tumor spectra between families with single and multiple cases of childhood tumors Cancer Research
06/04/2012
Abstract 5511: Cancer care-seeking patterns in Kumasi, Ghana Cancer Research
06/04/2012
Abstract 5510: Assessing the level of breast cancer awareness among recently diagnosed patients in Ain Shams University Hospital Cancer Research
06/04/2012
Abstract 5509: Liver cancer risk prediction model from a large prospective cohort in Taiwan Cancer Research
06/04/2012
Abstract 5508: Geographic clustering of melanoma malignum with high thickness in the United States Cancer Research
06/04/2012
Abstract 5507: Breast cancer in Jordan: A comprehensive epidemiological analysis 1996-2008 Cancer Research
06/04/2012
Abstract 5506: HPV genotyping of 15,307 Brazilian patients using a microarray based platform. Cancer Research
06/04/2012
Abstract 5505: Risk of second malignancies in patients with Chronic Lymphocytic Leukemia: A population based Canadian study Cancer Research
06/04/2012
Abstract 5504: Second neoplasms after childhood cancer and gene expression differences in primary fibroblasts Cancer Research
06/04/2012
Abstract 5503: A simple correction for population stratification in random forest analysis Cancer Research
06/04/2012
Abstract 5502: Prognostic tools for pancreatic cancer survival Cancer Research
06/04/2012
Abstract 5500: Phenotypic risk factors for malignant melanoma in-situ in US women and men Cancer Research
06/04/2012
Abstract 5499: A descriptive epidemiological study of lobular carcinoma of the breast and the effects of normal lobular regression at menopause Cancer Research
06/04/2012
Abstract 5497: Breast cancer treatment decision-making: Are we asking too much of patients Cancer Research
06/04/2012
Abstract 5496: Breast cancer screening and treatment quality metrics across an entire racially diverse metropolitan area: Chicago Cancer Research
06/04/2012
Abstract 5495: Does KRAS testing in metastatic colorectal cancer impact overall survival: A comparative effectiveness study in a population-based sample Cancer Research
06/04/2012
Abstract 5494: The development and validation of risk predictive models for cervical low-grade and high-grade squamous intraepithelial lesions Cancer Research
06/04/2012
Abstract 5493: Menopause-associated symptoms, HRT use and risk of young-onset breast cancer: Results from the Two Sister Study Cancer Research
06/04/2012
Abstract 5492: Use of beta blockers, ACE inhibitors, and angiotensin receptor blockers and risk of breast cancer recurrence: A Danish nationwide cohort study Cancer Research
06/04/2012
Abstract 5491: A history of allergies is associated with reduced risk of oral squamous cell carcinoma Cancer Research
06/04/2012
Abstract 5490: Prospective study of seroreactivity to JC virus T-Antigen and risk of colorectal cancers and adenomas Cancer Research
06/04/2012
Abstract 5489: Feasibility study of gut microbiome collection in randomly sampled women Cancer Research
06/04/2012
Abstract 5488: The rate of vertical transmission of human papillomavirus from mothers to infants: Relationship between infection rate and mode of delivery Cancer Research
06/04/2012
Abstract 5487: Investigating human herpesvirus 8 infection among adults in Uganda: A factor analysis approach Cancer Research
06/04/2012
Abstract 5486: Reliability of biomarkers of inflammation from repeated measures in healthy individuals Cancer Research
06/04/2012
Abstract 5485: Increased prevalence of light chain monoclonal gammopathy of undetermined significance (MGUS) in first-degree relatives of individuals with multiple myeloma or MGUS Cancer Research
06/04/2012
Abstract 5482: Sun exposure and prostate cancer risk in New South Wales, Australia: A case control study Cancer Research
06/04/2012
Abstract 5481: Mitochondrial DNA copy number and lung cancer risk among Chinese female non-smokers Cancer Research
06/04/2012
Abstract 5480: Consumption of Lake Ontario sport fish and the incidence of melanoma in the New York State Angler Cohort Study (NYSACS) Cancer Research
06/04/2012
Abstract 5479: Somatic driver mutations among never smoking female lung cancer cases in China identify unique mutation pattern that may be associated with household coal burning Cancer Research
06/04/2012
Abstract 5478: Indoor coal smoke exposure, tobacco use, and lung cancer risk in Xuanwei, China Cancer Research
06/04/2012
Abstract 5477: Ambient exposure to air pollutants and risk of neuroblastoma Cancer Research
06/04/2012
Abstract 5475: National survey of malignant mesothelioma and asbestos exposure in Japan Cancer Research
06/04/2012
Abstract 5474: Prediagnostic cytokine levels and the risk of non-Hodgkin lymphoma in a nested case-control study: The Multiethnic Cohort Cancer Research
06/04/2012
Abstract 5473: Integrative approach towards the functionality of CIAO1 gene Cancer Research
06/04/2012
Abstract 5472: Role of Harvey Ras (HRAS) mutations in head and neck squamous cell carcinoma (HNSCC) Cancer Research
06/04/2012
Abstract 5471: Implication of cytokines released from gingival fibroblasts exposed by areca nut extract in carcinogenesis Cancer Research
06/04/2012
Abstract 5470: Genotoxic effect and epigenetic alterations induced by the environmental carcinogen dibenzo[a, l]pyrene in oral tissues of mice Cancer Research
06/04/2012
Abstract 5469: Detection of deoxyguanosine adducts in the oral tissues of mice treated with the environmental carcinogen dibenzo[a, l]pyrene by LC-MS/MS Cancer Research
06/04/2012
Abstract 5468: Transgenic mice ectopically express miR-31 in basal keratinocyte, exhibit high potential for oral tumorigenesis Cancer Research
06/04/2012
Abstract 5467: Green tea catechin intervention of human breast cell carcinogenesis chronically induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine Cancer Research
06/04/2012
Abstract 5466: Butyrate effect on expression of quinone oxidoreductase (NQO1) and cytochrome P450 CYP1A1 enzymes Cancer Research
06/04/2012
Abstract 5465: Role of CYP2A13 in NNK bioactivation and lung tumorigenesis: In vivo studies using a CYP2A13-humanized mouse model Cancer Research
06/04/2012
Abstract 5464: Genotoxicity of multi-walled carbon nanotubes at occupationally relevant doses Cancer Research
06/04/2012
Abstract 5463: Serum aminotransferases and alkaline phosphatases as biomarkers of hepatotoxicity in sprague-dawley rats exposed to silver nanoparticles Cancer Research
06/04/2012
Abstract 5462: Single dose dermal irritation study of apaziquone in rabbits Cancer Research
06/04/2012
Abstract 5461: Role of the NLRP3 inflammasome in the development and drug resistance of malignant mesothelioma Cancer Research
06/04/2012
Abstract 5460: Effects of ethanol exposure during involution on mouse mammary gland Cancer Research
06/04/2012
Abstract 5459: Benzo(a)pyrene biotransformation enzyme expression, activities and metabolite disposition in ApcMin mouse colon and liver is altered by resveratrol exposure. Cancer Research
06/04/2012
Abstract 5458: GADD45{alpha} nickel induction inhibits JNKs/p38 activity by promoting PP2C{alpha} expression Cancer Research
06/04/2012
Abstract 5457: Chlorinated drinking water alters carcinogenesis in a mice model of colon cancer Cancer Research
06/04/2012
Abstract 5456: Potential role of nitric oxide in chromium-induced lung carcinogenesis Cancer Research
06/04/2012
Abstract 5455: Toxic heavy metal content in lung tissue samples from non-small cell lung cancer patients Cancer Research
06/04/2012
Abstract 5454: Genotoxic consequences of exposure to mixtures of food-derived chemical carcinogens Cancer Research
06/04/2012
Abstract 5453: The effect of ovarian hormones on the induction of mammary tumors induced by the environmental pollutant 6-nitrochrysene Cancer Research
06/04/2012
Abstract 5452: In utero exposure to bisphenol A promotes mammary tumor development in MMTV-erbB-2 transgenic mice Cancer Research
06/04/2012
Abstract 5451: Arsenic induced altered pathways in bladder cancer Cancer Research
06/04/2012
Abstract 5450: H-RASG12V transformation modulates antioxidant activities and enhances genotoxicity to arsenite in human urothelial cells Cancer Research
06/04/2012
Abstract 5449: Down-regulation of miR-200b and induction of ZEB1 and ZEB2 promote arsenic-transformed cell migration and invasion Cancer Research
06/04/2012
Abstract 5448: Common targets of epigenetic dysfunction in distinct target tissues of arsenic and cadmium induced malignant transformation Cancer Research
06/04/2012
Abstract 5447: Breast cancer chemoprevention by 'Jamun', the Indian blackberry: Potential mechanisms Cancer Research
06/04/2012
Abstract 5446: Green tea catechin intervention of reactive oxygen species-mediated ERK pathway activation, DNA damage, and chronically-induced breast cell carcinogenesis Cancer Research
06/04/2012
Abstract 5445: Polyphenolic phytochemical curcumin suppresses HER-2 protein phosphorylation and gene expression in breast cancer cells Cancer Research
06/04/2012
Abstract 5444: In vitro modeling for breast cancer prevention - omega-3 ethyl esters functioning as preventive agents in 21T series models Cancer Research
06/04/2012
Abstract 5443: Prevention of breast cancer by spices: Involvement of miRNA and other molecular targets Cancer Research
06/04/2012
Abstract 5442: MicroRNAs may mediate multigenerational epigenetic inheritance of mammary cancer risk caused by maternal exposure to high-fat diet during pregnancy Cancer Research
06/04/2012
Abstract 5441: Anticancer effects of 3,3'-diindolylmethane (DIM) in multiple T-cell acute lymphoblastic leukemia/lymphoma (T-ALL) cell lines Cancer Research
06/04/2012
Abstract 5440: Upregulation of prostaglandin E2 and TGF-alpha by linoleic acid enhances pro-oncogenic signaling in models of human lung and breast cancer Cancer Research
06/04/2012
Abstract 5439: Inhibition of growth and induction of differentiation of colon cancer cells by extracts from okra (Abelmoschus esculentus) and drumstick (Moringa oleifera) Cancer Research
06/04/2012
Abstract 5438: Oral administration of naturally occurring chitosan based nanoformulated green tea polyphenol EGCG effectively inhibits prostate cancer cell growth in a xenograft model Cancer Research
06/04/2012
Abstract 5436: The role of reactive oxygen species in (-)-epigallocatechin-3-gallate (EGCG)-induced cell growth inhibition and apoptosis in oral cancer cells Cancer Research
06/04/2012
Abstract 5435: Tolcapone inhibits catechol-O-methyl transferase-mediated methylation of (-)-epigallocatechin-3-gallate in vivo Cancer Research
06/04/2012
Abstract 5434: Oxidative stress analysis in peripheral blood mononuclear cells of pediatric leukemia undergoing chemotherapy: Correlations with dietary intake Cancer Research
06/04/2012
Abstract 5433: Dietary factors and the risk of esophageal cancer: A population-based cohort study in Korea Cancer Research
06/04/2012
Abstract 5432: The effect of folic acid supplementation on chemosensitivity of colon cancer cells to 5-fluorouracil in a xenograft model Cancer Research
06/04/2012
Abstract 5431: Effects of various dietary fibers on intestinal carcinogenesis in Min mice Cancer Research
06/04/2012
Abstract 5584: Disregulation of phosphorelated Amplified In Breast Cancer3 (AIB3) contributes to poor prognosis and mediates trastuzumab efficacy in breast cancer patients Cancer Research
06/04/2012
Abstract 5583: Decrease in expression of Gadd45 is associated with gemcitabine and hydroxyurea resistance in human head and neck squamous-cell carcinoma Cancer Research
06/04/2012
Abstract 5581: A non-coding RNA panel is prognostically superior to standard pathologic criteria and coding transcripts in rhabdomyosarcoma Cancer Research
06/04/2012
Abstract 5580: Membrane-Type 1 Matrix Metalloproteinase (MT1-MMP): A predictive biomarker of chemotherapy response in osteosarcoma Cancer Research
06/04/2012
Abstract 5579: Genomic approach to the prediction of chemotherapeutic sensitivity in osteosarcoma Cancer Research
06/04/2012
Abstract 5578: IGF-1R nuclear staining in tumor cells identifies sarcoma patients with a prolonged progression free survival after IGF-1R monoclonal antibody therapy Cancer Research
06/04/2012
Abstract 5577: HER2 cytoplasmic staining and penile cancer Cancer Research
06/04/2012
Abstract SY18-01: Hypoxia, metabolism, and tumor progression Cancer Research
06/04/2012
Abstract SY17-02: Mechanisms driving dormancy of disseminated tumor cells Cancer Research
06/04/2012
Abstract SY17-01: Intratumor diversity in breast cancer Cancer Research
06/04/2012
Abstract SY16-01: Clinical trial design to match patients to treatment based on molecular profiling of tumors Cancer Research
06/04/2012
Abstract SY15-01: Cellular context-specific tumor suppression by PTPN11 Cancer Research
06/04/2012
Abstract SY14-02: p53-mediated senescence impairs the apoptotic response to chemotherapy in breast cancer Cancer Research
06/04/2012
Abstract SY14-01: Investigating MTORC1 inhibition downstream of Apc loss in vivo Cancer Research
06/04/2012
Abstract SY13-03: Molecular imaging for advanced practice in oncology Cancer Research
06/04/2012
Abstract SY13-02: In vivo cancer theranostics Cancer Research
06/04/2012
Abstract SY13-01: Reporter imaging in cancer biology and therapy Cancer Research
06/04/2012
Abstract SY12-02: Epstein-Barr virus (EBV) and cancer: Opportunities for etiologic research and prevention Cancer Research
06/04/2012
Abstract SY12-01: HPV vaccines: The opportunity to prevent multiple cancers Cancer Research
06/04/2012
Abstract SY11-03: Mechanisms of ATM activation Cancer Research
06/04/2012
Abstract SY11-02: Microenvironment matters: TGF{beta} regulates the response to DNA damage Cancer Research
06/04/2012
Abstract SY11-01: Targeting the Fanconi anemia/BRCA pathway in cancer therapy Cancer Research
06/04/2012
Abstract SY10-04: Delineating cellular targets of transformation in breast cancer Cancer Research
06/04/2012
Abstract SY10-03: Cell of origin in pediatric medulloblastomas Cancer Research
06/04/2012
Abstract SY10-02: Mouse models for (non) small cell lung cancer: Heterogeneity and cell of origin Cancer Research
06/04/2012
Abstract SY10-01: Uncovering the cellular origin of skin cancers Cancer Research
06/04/2012
Abstract SY09-03: Racial and ethnic differences in cancer risk models Cancer Research
06/04/2012
Abstract SY09-02: Molecular mechanisms in prostate cancer in African Americans Cancer Research
06/04/2012
Abstract SY09-01: Increased colorectal cancer burden among African Americans: Access, utilization, or biology Cancer Research
06/04/2012
Abstract SY08-02: Gene regulatory network models identify targets for mammary tumor normalization Cancer Research
06/04/2012
Abstract SY08-01: Large-scale screens for cancer genes in the mouse Cancer Research
06/04/2012
Abstract SY07-03: The ubiquitin-based response to DNA double-strand breaks Cancer Research
06/04/2012
Abstract SY07-02: Involvement of ubiquitin ligase RNF4 in the DNA damage response Cancer Research
06/04/2012
Abstract SY07-01: Functions of ubiquitin and SUMO in DNA damage bypass Cancer Research
06/04/2012
Abstract SY06-02: The nontraditional peptide therapeutics Cancer Research
06/04/2012
Abstract SY06-01: Intracellular antibody therapy: Specific delivery of synthetic antibodies to cytoplasmic targets in cancer cells Cancer Research
06/04/2012
Abstract SY05-03: microRNAs, EMT, and cancer stem cells Cancer Research
06/04/2012
Abstract SY05-02: Novel roles for microRNAs in metastatic progression Cancer Research
06/04/2012
Abstract SY05-01: microRNAs: Micromanagers of human cancers Cancer Research
06/04/2012
Abstract PL04-03: Cell signaling by receptor tyrosine kinases: From basic principles to cancer therapy Cancer Research
06/04/2012
Abstract SY04-02: Reaching escape velocity: Using lineage tracing to study EMT and dissemination in pancreatic cancer Cancer Research
06/04/2012
Abstract PL04-02: Ras and Raf signaling: From biology to therapeutics Cancer Research
06/04/2012
Abstract SY04-01: Skin stem cells in silence, action, and cancer Cancer Research
06/04/2012
Abstract PL04-01: Overcoming cancer drug resistance Cancer Research
06/04/2012
Abstract LB-339: Cause of death in cancer survivors Cancer Research
06/04/2012
Abstract LB-338: A prospective evaluation of circulating sex hormones in relation to colorectal cancer risk in men and women Cancer Research
06/04/2012
Abstract LB-337: Synergistic effects of twelve common genetic polymorphisms and smoking habits on absolute risk of bladder cancer Cancer Research
06/04/2012
Abstract LB-336: Association of variant rs2046210 at 6q25.1 (ESR1) with breast cancer risk suggests heterogeneity by E-cadherin tumor tissue expression Cancer Research
06/04/2012
Abstract LB-335: Associations of functional polymorphisms in genes involved in the MAPK signaling pathways and cutaneous melanoma risk Cancer Research
06/04/2012
Abstract LB-334: Functional polymorphisms in the stem-cell related pathway affect susceptibility to non-small cell lung cancer: a finding from Texas lung cancer genome-wide association study Cancer Research
06/04/2012
Abstract LB-333: A case-parent-triad approach in assessing risk of osteosarcoma associated with genetic variation in insulin-like growth factor 1/growth hormone axis genes: a Children's Oncology Group (COG) study Cancer Research
06/04/2012
Abstract LB-332: Hormone metabolism pathway genes associated with mammographic density change induced by postmenopausal combined estrogen and progestin therapy Cancer Research
06/04/2012
Abstract LB-331: Polymorphisms in inflammation pathway genes and endometrial cancer Cancer Research
06/04/2012
Abstract LB-330: Genetic variants in the 9p21 region in relation to the risk of multiple tumors Cancer Research
06/04/2012
Abstract LB-329: Use of insulin sensitizers is associated with better hormone-receptor pattern and improved breast cancer outcomes Cancer Research
06/04/2012
Abstract LB-328: Plasma antibodies to oral pathogen and commensals and risk of pancreatic cancer in a large European prospective cohort study Cancer Research
06/04/2012
Abstract LB-327: Validation of a breast cancer risk prediction model in African American women Cancer Research
06/04/2012
Abstract LB-326: Elucidating significant genetic associations between genes and lung cancer Cancer Research
06/04/2012
Abstract LB-325: Characterization of triple negative breast cancer patients among Hispanics in Puerto Rico Cancer Research
06/04/2012
Abstract LB-324: The cancer risks and life shortening effect of low and very low cholesterol among Asians Cancer Research
06/04/2012
Abstract LB-323: Self-reported sleep duration and subsequent risk of colorectal cancer in two large cohorts of women and men Cancer Research
06/04/2012
Abstract LB-322: Cruciferous vegetable intake after diagnosis of breast cancer and survival: a report from the shanghai breast cancer survival study Cancer Research
06/04/2012
Abstract LB-320: Identification of USP37 as a novel tumor suppressive p27-specific deubiquitylase Cancer Research
06/04/2012
Abstract LB-318: Pediatric Preclinical Testing Program (PPTP) evaluation of the JAK inhibitor AZD1480 Cancer Research
06/04/2012
Abstract LB-317: Pediatric Preclinical Testing Program (PPTP) evaluation of volasertib (BI 6727), a Polo-like kinase (PLK) inhibitor Cancer Research
06/04/2012
Abstract LB-316: Pharmacokinetic modeling optimizes direct inhibition of the 'undruggable' target EWS-FLI1 of Ewing Sarcoma Cancer Research
06/04/2012
Abstract LB-315: Suppression of tumor invasion and metastasis by inhibition of c-MET and VEGF signaling together Cancer Research
06/04/2012
Abstract LB-314: CSF-1R inhibitor JNJ-28312141 reduces antiangiogenic therapy-induced myeloid cell infiltration and mesenchymal shift Cancer Research
06/04/2012
Abstract LB-313: ALK1-Fc inhibits tumor growth in a VEGF pathway resistance model of renal cell carcinoma Cancer Research
06/04/2012
Abstract LB-312: Egfl7 is expressed in a broad range of human tumors with apparent restriction to the endothelium Cancer Research
06/04/2012
Abstract LB-311: Inhibition of angiopoietin and Dll4 signaling in the tumor vasculature leads to increased efficacy in mouse tumor xenograft models Cancer Research
06/04/2012
Abstract LB-310: Changes in the gene expression profile of A375 human melanoma cells induced by over-expression of multifunctional pigment epithelium-derived factor Cancer Research
06/04/2012
Abstract LB-309: The heparan sulfate mimetic PG545 increases plasma VEGF and FGF-2 in advanced cancer patients, and significantly inhibits tumor growth in preclinical models of ovarian cancer - implications for future therapy Cancer Research
06/04/2012
Abstract LB-308: Combination of CTx-0294945 a highly selective inhibitor of focal adhesion kinase with bevacizumab in pre-clinical models of breast cancer Cancer Research
06/04/2012
Abstract LB-307: Modeling the breast cancer metastatic niche Cancer Research
06/04/2012
Abstract LB-306: Multiplex RT-qPCR study on the expression of stem cell markers CD24, CD44, and ALDH1 in circulating tumor cells of breast cancer patients Cancer Research
06/04/2012
Abstract LB-305: Circulating tumor cells as a novel model to test efficacy of individualized therapy in breast cancer Cancer Research
06/04/2012
Abstract LB-304: Sp1 expression regulates lung tumor progression Cancer Research
06/04/2012
Abstract PL03-03: The rational combination of BRAF inhibition with immunotherapy for the treatment of metastatic melanoma Cancer Research
06/04/2012
Abstract LB-303: Metastasis suppression by MDM2 binding protein through inhibition of ACTN4 function Cancer Research
06/04/2012
Abstract PL03-02: Current status of recombinant pox-viral vaccines Cancer Research
06/04/2012
Abstract LB-302: Coordinate upregulation of pluripotency factors in a hybrid epithelial/mesenchymal state in anoikis resistant suspended breast epithelial cells Cancer Research
06/04/2012
Abstract SY03-01: Revealing new metabolic networks in cancer Cancer Research
06/04/2012
Abstract PL03-01: CAR T cells for leukemia and more Cancer Research
06/04/2012
Abstract LB-301: Galectin-3 contributes to melanoma metastasis by regulating Autotaxin through NFAT1 Cancer Research
06/04/2012
Abstract LB-300: The role of WNT7B in prostate cancer bone metastasis Cancer Research
06/04/2012
Abstract LB-299: Prognostic impact of EMT (epithelial-mesenchymal-transition) related protein expression in endometrial cancer Cancer Research
06/04/2012
Abstract LB-298: EGF induces EMT through PI3K/Akt and MAPK singnaling pathways in breast cancer cell lines Cancer Research
06/04/2012
Abstract LB-297: The EMT inhibitor AB-16B5 interacts with specific isoforms of secreted clusterin Cancer Research
06/04/2012
Abstract LB-296: Allikrein 14 induces epithelial-mesenchymal transition-like changes in colon cancer cells Cancer Research
06/04/2012
Abstract LB-295: Targeted therapy of human osteosarcoma cell lines Cancer Research
06/04/2012
Abstract LB-294: Transforming growth factor beta 3 (TGF-ss3) contributes to epithelial-mesenchymal transitions (EMT) in human prostate cancer Cancer Research
06/04/2012
Abstract LB-293: High-throughput proteomic analysis identifies protein s as a modulator of high grade and castrate-resistant prostate cancer Cancer Research
06/04/2012
Abstract LB-292: NANOG promotes chemoresistance in prostate carcinoma cells Cancer Research
06/04/2012
Abstract LB-291: Role of exosomes in tumor cell adhesion and survival Cancer Research
06/04/2012
Abstract LB-289: A novel role for the p19ARF tumor suppressor in chromosome segregation Cancer Research
06/04/2012
Abstract LB-288: The role of CUL3 in spindle assembly Cancer Research
06/04/2012
Abstract LB-287: TPX2 acts as a scaffold and co-activator protein for the oncogenic kinase Aurora B Cancer Research
06/04/2012
Abstract LB-286: 3p24 tumor suppressor gene RBMS3 in NPC Cancer Research
06/04/2012
Abstract LB-285: Regulation of therapy resistance in slow-cycling cancer cells Cancer Research
06/04/2012
Abstract LB-284: Retinoblastoma tumor suppressor protein phosphorylation and inactivation depend on direct interaction with Pin1 Cancer Research
06/04/2012
Abstract LB-283: Aurora B binds p53 during both interphase and mitosis, phosphorylates it and promotes its degradation Cancer Research
06/04/2012
Abstract LB-282: Myxovirus (influenza virus) resistance 1 (MX1) polymorphism in prostate cancer Cancer Research
06/04/2012
Abstract LB-281: Hodgkin Lymphoma requires stabilized NIK and constitutive RelB expression for survival Cancer Research
06/04/2012
Abstract LB-280: RNP biogenesis factor Thoc1 is targeted for ubiquitination by NEDD4-1 E3 ligase Cancer Research
06/04/2012
Abstract LB-279: SIRT6 expression is regulated by cAMP signaling system in non small cell lung cancer cells Cancer Research
06/04/2012
Abstract LB-278: MicroRNA control of GNA13 expression and cancer cell invasion Cancer Research
06/04/2012
Abstract LB-277: Global translational regulation by miR-520c Cancer Research
06/04/2012
Abstract LB-276: 2-D DIGE and siRNA to find new cancer targets Cancer Research
06/04/2012
Abstract LB-275: Genome-wide analysis of the vitamin D receptor (VDR) binding sites reveals vitamin D role mediating autophagy in luminal-like breast cancer cells Cancer Research
06/04/2012
Abstract LB-274: Mutant p53 cooperates with ETS2 to promote etoposide resistance Cancer Research
06/04/2012
Abstract LB-273: Transcriptional regulation by androgen receptor in prostate cancer Cancer Research
06/04/2012
Abstract LB-272: A novel isoform of Sox5 is expressed in TRAF3-deficient mouse B lymphomas Cancer Research
06/04/2012
Abstract LB-271: Loss of the transcription factor REST promotes breast cancer tumorigenicity in a LIN28-dependent manner Cancer Research
06/04/2012
Abstract LB-270: Genomic amplification of c-Jun activates genes that promote proliferation and cell migration in liposarcoma Cancer Research
06/04/2012
Abstract LB-269: A new role for the gain-of-function activity of p53 in breast cancer Cancer Research
06/04/2012
Abstract LB-268: Loss of HPV16 E2 protein expression and transcriptional modulation of cellular and viral genes correlate with progression to cervical carcinoma Cancer Research
06/04/2012
Abstract LB-267: A role for the Sin3 histone deacetylase complex in cell migration Cancer Research
06/04/2012
Abstract LB-266: Expression of AGR2 in lung cancer cells needs an active Hippo pathway co-activator, YAP1 Cancer Research
06/04/2012
Abstract LB-264: Axitinib improves radiotherapy for murine xenograft lung tumors Cancer Research
06/04/2012
Abstract LB-263: Synthetic lethal targeting of PTEN-associated homologous recombination (HR) deficient melanoma cells by human apurinic/apyrimidinic endonuclease (APE1) inhibitors Cancer Research
06/04/2012
Abstract LB-262: Targeting T-type calcium channels induces the extrinsic apoptotic pathway and sensitizes glioblastoma cancer cells to radio- and chemotherapy Cancer Research
06/04/2012
Abstract LB-261: A novel notch-AKT-NF-KB axis in triple negative breast cancer cells Cancer Research
06/04/2012
Abstract LB-260: Identification of DTYMK and CHEK1 as therapeutic targets in LKB1 mutant non-small cell lung cancer Cancer Research
06/04/2012
Abstract LB-259: Knockdown of slingshot2 serine phosphatase induces caspase3 activation in human carcinoma cell lines with the loss of the Birt-Hogg-Dube tumor suppressor gene Cancer Research
06/04/2012
Abstract LB-258: Developing therapeutic siRNA against HER2 in breast cancer cells Cancer Research
06/04/2012
Abstract LB-257: Ganitumab (AMG 479), an anti IGF-1R antibody, inhibits the proliferation of melanoma cells Cancer Research
06/04/2012
Abstract LB-256: Targeting MLL1 methyltransferase activity for treatment of acute leukemia with MLL1 rearrangement Cancer Research
06/04/2012
Abstract LB-254: PRMT5 is upregulated in malignant and metastatic melanoma, and regulates expression of the MITF transcription factor Cancer Research
06/04/2012
Abstract LB-252: Enzymology of the mechanism of action for MDX-1203 antibody drug conjugate Cancer Research
06/04/2012
Abstract LB-251: Manipulation of macrophage phenotype enhances the apoptotic response to chemotherapy in mesothelioma Cancer Research
06/04/2012
Abstract LB-250: 2-Deoxy-D-glucose cytotoxicity relies on both glycolysis inhibition and ER stress induction, and is efficacious in a variety of human lymphoma models Cancer Research
06/04/2012
Abstract LB-249: Characterization of a novel potent and selective CDK4/6 inhibitor and a resistance mechanism Cancer Research
06/04/2012
Abstract LB-248: Investigation of tumor cell activity of Abiraterone using in vitro model systems of androgen (A)-responsive prostate cancer Cancer Research
06/04/2012
Abstract LB-247: mTORC1 enhances bortezomib-induced death in TSC-null cells by a c-MYC-dependent induction of the unfolded protein response Cancer Research
06/04/2012
Abstract LB-246: Epithelial-mesenchymal transition (EMT) does not necessarily decrease the sensitivity of cancer cells to chemotherapeutic agents Cancer Research
06/04/2012
Abstract 5370: Adjuvant breast cancer vaccine improves overall survival of patients with depressed immunity Cancer Research
06/04/2012
Abstract 5368: A phase II study of ipilumimab plus androgen deprivation therapy in castration-sensitive prostate carcinoma Cancer Research
06/04/2012
Abstract 5367: Long-term survival in a phase II atudy of belagenpumatucel-L (TGF-{beta} antisense modified tumor cell vaccine) in non-small cell lung cancer (NSCLC). Cancer Research
06/04/2012
Abstract 5366: Extended phase II study of maintenance immunotherapy in advanced cancer Cancer Research
06/04/2012
Abstract 5365: Prolonged survival of patients with advanced renal cancer responding to multi-peptide vaccine IMA901 after single-dose cyclophosphamide Cancer Research
06/04/2012
Abstract 5364: Correlation of immune responses and overall survival in a phase II study of belagenpumatucel-L, an allogeneic tumor cell vaccine, in non-small cell lung cancer (NSCLC) Cancer Research
06/04/2012
Abstract 5363: Aggregation rather than monoclonal expansion explains ovarian cancer spheroid formation Cancer Research
06/04/2012
Abstract 5362: Multidrug-resistance (MDR-1) gene expression in immature glioma cells Cancer Research
06/04/2012
Abstract 5361: Enriching and characterizing cancer stem cell grown on collagen type IV-coated plate in primary pediatric brain tumors Cancer Research
06/04/2012
Abstract 5360: Towards identification of cancer stem cells in esophageal adenocarcinoma Cancer Research
06/04/2012
Abstract 5359: Gene expression characterization of different cancer stem cell isolation methods in head and neck cancer Cancer Research
06/04/2012
Abstract 5358: Comparison of tumor-forming ability in different fractions of pancreatic ductal adenocarcinoma cells Cancer Research
06/04/2012
Abstract 5357: Evaluation of colony formation and growth of malignant glioma cells in soft agar using advanced colony counter system Cancer Research
06/04/2012
Abstract 5356: In search for mutually exclusive marker signatures for glioma initiating cells (GICs) and non-GICs, respectively Cancer Research
06/04/2012
Abstract 5355: Immunohistochemical variations in the expression of cancer stem cell and macrophage markers in primary and recurrent oral squamous cell carcinomas Cancer Research
06/04/2012
Abstract 5354: Nuclear spheres in developmental biology and diagnosis Cancer Research
06/04/2012
Abstract 5353: Characterization of breast cancer stem cells (BCSCs) in Egyptian breast cancer patients through genetic profiling using the RT-PCR and quantitative real time microarray Cancer Research
06/04/2012
Abstract 5352: Investigation of stem-cell markers in pleomorphic adenoma: Immunohistochemical and molecular study Cancer Research
06/04/2012
Abstract 5350: Aldehyde dehydrogenase 1 is useful for identifying some subtypes of non-basal triple negative breast cancer Cancer Research
06/04/2012
Abstract 5349: Cancer stem cells isolation and characterization from breast tumor of a germline carrier of TP53 p.R337H (Brazilian founder) mutation Cancer Research
06/04/2012
Abstract 5348: Transduction of tumors in vivo with choline kinase shRNA downregulates breast cancer stem cell markers Cancer Research
06/04/2012
Abstract 5347: Identification of differentially expressed proteins in breast cancer stem cells using proteomic profiling Cancer Research
06/04/2012
Abstract 5346: Tumor cell heterogeneity and chromosomal abnormality in malignant pleural effusion (MPE) samples of lung cancer Cancer Research
06/04/2012
Abstract 5345: Cancer stem-like cell markers in stage I and II breast cancer Cancer Research
06/04/2012
Abstract 5344: Subtyping of glioblastoma stem-like cancer cells with neural lineage markers predicts invasiveness and correlates with survival Cancer Research
06/04/2012
Abstract 5343: Identification of brain tumor initiating cells using the stem cell marker aldehyde dehydrogenase 1 Cancer Research
06/04/2012
Abstract 5342: FC-IBC-02: A new in vitro-in vivo model of inflammatory breast cancer (IBC) Cancer Research
06/04/2012
Abstract 5341: Proliferative activity of human colon TIC in sphere cultures Cancer Research
06/04/2012
Abstract 5340: Standardization of cancer stem cell enumeration and isolation methods allows cross comparison among different tumor entities Cancer Research
06/04/2012
Abstract 5339: Breast cancer stem cells predict engraftment in vivo of primary tumor and are characterized by a gene expression signature associated with poor prognosis. Cancer Research
06/04/2012
Abstract 5338: Pancreatic cancer tumor initiating cells are marked by the presence of cell surface associated acetylated alpha tubulin Cancer Research
06/04/2012
Abstract 5337: Laminin alpha 2 enables glioblastoma stem cell growth Cancer Research
06/04/2012
Abstract 5336: Distinct liver cancer stem cells defined by EpCAM and CD90 in human hepatocellular carcinoma Cancer Research
06/04/2012
Abstract 5335: Identification and molecular characterization of pancreatic tumor-initiating cells Cancer Research
06/04/2012
Abstract 5334: Novel lentiviral barcoding strategy for lineage tracing of cancer stem cells Cancer Research
06/04/2012
Abstract 5333: EpCAM overexpression in metastasizing gastric carcinomas Cancer Research
06/04/2012
Abstract 5332: Snail transcription factor contributes to prostate cancer tumor progression via reactive oxygen species and Rac1 activation Cancer Research
06/04/2012
Abstract 5331: The effect of heat shock protein 27 (HSP27) on prostate cancer cell adhesion, invasion and metastasis Cancer Research
06/04/2012
Abstract 5330: Androgen independent promotion of prostate cancer cell invasion by HOXB13-mediated zinc regulation Cancer Research
06/04/2012
Abstract 5329: Induction of VEGF-C expression via mGluR5 in the lymph node metastases of oral cancer by the SDF-1/CXCR4 system Cancer Research
06/04/2012
Abstract 5328: Interleukin-4 receptor regulates metastasis of mammary epithelial cancer cells Cancer Research
06/04/2012
Abstract 5327: An N-terminal truncated carboxypeptidase E splice isoform induces metastasis by activating nedd9 and other metastasis inducing genes Cancer Research
06/04/2012
Abstract SY42-02: Novel PET imaging in the clinic: Selecting patient cohorts and measuring early response Cancer Research
06/04/2012
Abstract SY42-01: MRI/MRS of tumor microenvironment Cancer Research
06/04/2012
Abstract SY41-04: Targeting Semaphorin 3A: A new tool to normalize tumor vasculature and to overcome the evasive resistance to the anti-angiogenic therapy Cancer Research
06/04/2012
Abstract SY41-03: Vascular normalization by histidine-rich glycoprotein Cancer Research
06/04/2012
Abstract SY41-02: Tumor cell effects of vascular reprogramming: Contributions of c-MET and VEGF Cancer Research
06/04/2012
Abstract SY41-01: Tumor-endothelial transdifferentiation Cancer Research
06/04/2012
Abstract SY40-03: The FAP+ stromal cell: Cancer-induced immune suppression and cachexia Cancer Research
06/04/2012
Abstract SY40-02: Interplay between microenvironment and cancers Cancer Research
06/04/2012
Abstract SY40-01: Anti-CD40 as an anticancer agent Cancer Research
06/04/2012
Abstract SY39-01: Harnessing cancer genome diversity for intervention target discovery and development Cancer Research
06/04/2012
Abstract SY38-04: Altered metabolic enzymes and metabolites in cancer Cancer Research
06/04/2012
Abstract SY38-03: Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukemia Cancer Research
06/04/2012
Abstract SY38-02: Molecular oncogenesis of human T-cell lymphoma: Common features with myeloid malignancies Cancer Research
06/04/2012
Abstract SY38-01: Genetic and epigenetic changes contributing to leukemogenesis and prognostic impact in acute myeloid leukemia Cancer Research
06/04/2012
Abstract SY37-03: Targeting developmental pathways in colon cancer cells and stem cells Cancer Research
06/04/2012
Abstract SY37-02: Cell polarity proteins and cancer progression Cancer Research
06/04/2012
Abstract SY37-01: Cilia and wounding cooperate with Hedgehog signaling to initiate basal cell carcinoma Cancer Research
06/04/2012
Abstract SY36-04: Analysis of autophagy functions in mouse models of breast cancer Cancer Research
06/04/2012
Abstract SY36-03: Development of small-molecule inhibitors of autophagy as anticancer therapy Cancer Research
06/04/2012
Abstract SY36-02: Autophagy in cell death and cancer Cancer Research
06/04/2012
Abstract SY36-01: Mechanisms of autophagy addiction in cancer Cancer Research
06/04/2012
Abstract SY35-03: Gene expression and epigenetic programs in leukemia stem cell development Cancer Research
06/04/2012
Abstract SY35-02: Phenotypic heterogeneity and instability of human serous ovarian cancer tumor-initiating cells Cancer Research
06/04/2012
Abstract SY35-01: Clonal evolution of pre-leukemic hematopoietic stem cells precedes human acute myeloid leukemia Cancer Research
06/04/2012
Abstract SY34-01: Genome-wide association studies in cancer: A step in the right direction Cancer Research
06/04/2012
Abstract SY33-01: The development of crizotinib in molecularly targeted patient populations Cancer Research
06/04/2012
Abstract SY32-03: Promoting tissue-specific antitumor immunity Cancer Research
06/04/2012
Abstract SY32-02: Update on clinical results and correlative immunologic analysis of ipilimumab in patients with melanoma Cancer Research
06/04/2012
Abstract SY32-01: The immunologic constant of rejection and cancer Cancer Research
06/04/2012
Abstract SY31-04: Impact of cytokines on neurocircuits relevant to anxiety, depression, and fatigue in cancer patients Cancer Research
06/04/2012
Abstract SY31-03: Inflammatory mechanisms of cancer-related fatigue Cancer Research
06/04/2012
Abstract SY31-02: Behavioral consequences of peripheral tumors: Neuroimmune mechanisms Cancer Research
06/04/2012
Abstract SY31-01: Stress, anxiety, and susceptibility to squamous cell carcinoma: Role of immune mediators Cancer Research
06/04/2012
Abstract SY30-01: Evolution and dynamics of pancreatic cancer progression Cancer Research
06/04/2012
Abstract SY29-03: Regulation and function of the Hippo-YAP pathway in organ size, tumorigenesis, and metastasis Cancer Research
06/04/2012
Abstract SY29-02: The TSC-mTOR pathway and control of anabolic tumor cell metabolism Cancer Research
06/04/2012
Abstract SY29-01: mTOR, metabolism, and cell growth control Cancer Research
06/04/2012
Abstract SY28-04: Targeting the tumor extracellular matrix with armed antibodies Cancer Research
06/04/2012
Abstract SY28-03: The dynamic interplay between extrinsic and intrinsic force regulates cancer progression Cancer Research
06/04/2012
Abstract SY28-02: Interactions between cancer stem cells and their niche govern metastatic colonization Cancer Research
06/04/2012
Abstract SY28-01: Multiple changes in tumor extracellular matrices Cancer Research
06/04/2012
Abstract SY27-04: The signaling pathway of necrosome Cancer Research
06/04/2012
Abstract SY27-03: Development of necrostatins, small molecule inhibitors of RIP1-kinase signaling and necroptosis Cancer Research
06/04/2012
Abstract SY27-02: In vitro and in vivo regulation of regulated necrosis induced by TNF Cancer Research
06/04/2012
Abstract SY27-01: Cutting both ways: Why FADD, FLIP, and Caspase-8 are required for embryonic development Cancer Research
06/04/2012
Abstract SY26-03: Screening and strategies for liver cancer prevention Cancer Research
06/04/2012
Abstract SY26-02: SWOG S0701 phase III randomized trial of three antibiotic regimens to eradicate helicobacter pylori: efficacy and failure at one year Cancer Research
06/04/2012
Abstract SY26-01: Screening and cancer prevention in underdeveloped environments: A global view Cancer Research
06/04/2012
Abstract SY25-04: Sequencing the genome of acute lymphoblastic leukemia Cancer Research
06/04/2012
Abstract SY25-03: Host and tumor genetic architecture influence clinically relevant oncogenic pathways in neuroblastoma Cancer Research
06/04/2012
Abstract SY25-02: Recent advances in the genomics and genetics of the medulloblastomas: The impact of intertumoral and intratumoral heterogeneity Cancer Research
06/04/2012
Abstract SY25-01: Analysis of next-generation sequencing data for cancer genomes: challenges and pitfalls Cancer Research
06/04/2012
Abstract SY24-02: Imaging immune responses in cancer patients Cancer Research
06/04/2012
Abstract SY24-01: Use of imaging to guide the development of immune cell therapies Cancer Research
06/04/2012
Abstract SY23-03: Exploiting oncogene-induced replicative stress for the targeting of cancer cells Cancer Research
06/04/2012
Abstract SY23-02: A telomere-dependent DNA damage checkpoint induced by prolonged mitotic arrest Cancer Research
06/04/2012
Abstract SY23-01: Extrachromosomal microDNAs and chromosomal microdeletions in normal tissues Cancer Research
06/04/2012
Abstract SY22-02: Mammalian functional genetic signatures identify efficacy landscapes of combination chemotherapy Cancer Research
06/04/2012
Abstract SY22-01: Multiscale perspective of combination therapy for human cancer Cancer Research
06/04/2012
Abstract SY21-02: DNA methylation and epigenetic instability in human cancer Cancer Research
06/04/2012
Abstract SY21-01: Chromatin remodeling proteins in transcription and development Cancer Research
06/04/2012
Abstract SY20-02: Role of Polycomb repressors in stem cells, cancer, DNA repair and iPS cell reprogramming Cancer Research
06/04/2012
Abstract SY20-01: CHD5: Chromosome engineering, chromatin dynamics and cancer Cancer Research
06/04/2012
Abstract SY19-02: Novel models and treatments targeting the HER-AKT pathway in cancers that overexpress HER2 Cancer Research
06/04/2012
Abstract SY19-01: Integrating proteomic, transcriptional, epigenomic, and interactome data reveals the signaling changes induced by oncogenic mutations Cancer Research
06/04/2012
Abstract 5430: Analysis of genome-wide DNA methylation in CCRF-CEM cells confirms hypermethylation at reported epigenetic markers of T-cell lymphoblastic leukemia and identifies novel therapeutic targets with reduced methylation upon treatment with dietary indoles Cancer Research
06/04/2012
Abstract 5428: Consumption of S-allylcysteine inhibits tumor growth and progression in a mouse xenograft model of oral cancer Cancer Research
06/04/2012
Abstract 5426: Effects of dietary fatty acids on mammary macrophages in HER-2/neu-mediated mammary carcinogenesis Cancer Research
06/04/2012
Abstract 5425: The catalytic subunit of DNA-dependent protein kinase is downstream of ATM and feeds forward oxidative stress in selenium-induced senescence response Cancer Research
06/04/2012
Abstract 5423: Diet induced obesity, inflammation and prostate cancer progression in Hi-Myc mice Cancer Research
06/04/2012
Abstract 5422: Verification of the preventive effects of Lactobacillus casei Shirota and soymilk on breast cancer in animal model Cancer Research
06/04/2012
Abstract 5421: Stage specific inhibitory effect and associated mechanisms of insositol hexaphosphate on tumor progression and angiogenesis in TRAMP model Cancer Research
06/04/2012
Abstract 5420: The effect of folate deficiency on chemosensitivity of colon cancer cells to 5-Fluorouracil Cancer Research
06/04/2012
Abstract 5419: Targeting colon cancer stem cells using sulforaphane Cancer Research
06/04/2012
Abstract 5418: {alpha}-Mangostin, a dietary xanthone, inhibits ectopic xenograft growth of pancreatic cancer cells in an athymic nude mice Cancer Research
06/04/2012
Abstract 5417: Expansion of effector regulatory T-cells represents a novel and independent prognostic factor marking escape from immune surveillance in Myleodysplastic Syndrome Cancer Research
06/04/2012
Abstract 5416: Myeloid-derived suppressor cells (MDSC) are increased and correlated with immune suppression and chronic inflammation in patients with cancer Cancer Research
06/04/2012
Abstract 5415: Expression of immunosuppressive leukocyte inhibitory immunoglobulin like transcript 3(ILT3) receptors increases with the development and progression of ovarian tumors Cancer Research
06/04/2012
Abstract 5414: Malignant monocytic AML cells trigger apoptosis in anti-leukemic lymphocytes: Role of NADPH oxidase gp91phox expression and PARP-1 activity Cancer Research
06/04/2012
Abstract 5412: CCR4+CCR6+Th17 cells suppress autologous CD8+ T cell responses in patients with hepatocellular carcinoma Cancer Research
06/04/2012
Abstract 5411: Rb1 controls the differentiation of myeloid-derived suppressor cells subsets Cancer Research
06/04/2012
Abstract 5410: Tim-3 expression and function in natural killer cells from metastatic melanoma patients Cancer Research
06/04/2012
Abstract 5409: Cancer immunosuppression: The role of human leukocyte antigen G expression Cancer Research
06/04/2012
Abstract 5408: CD73 as a target in cancer immunotherapy Cancer Research
06/04/2012
Abstract 5406: Glioblastoma derived exosomes induce apoptosis in T cells Cancer Research
06/04/2012
Abstract 5405: Immuno-phenotyping reveals cell types present in circulation of breast cancer patients and elucidates their funstional potential Cancer Research
06/04/2012
Abstract 5404: Up-regulation of proliferative and migratory genes in regulatory T cells from patients with metastatic castration-resistant prostate cancer Cancer Research
06/04/2012
Abstract 5403: Snail+ bone-metastatic cancer cells impair CTL induction via induction of immunoregulatory MSCs Cancer Research
06/04/2012
Abstract 5402: Functionally altered plasmacytoid DC in breast tumor environment play a central role in Treg and Tr1-like expansion through ICOS engagement Cancer Research
06/04/2012
Abstract 5401: The influences of morphine on dendritic cell-mediated immunity Cancer Research
06/04/2012
Abstract 5399: S100A9 drives MDSC migration and contributes to tumor progression by inhibiting the immune response Cancer Research
06/04/2012
Abstract 5398: Direct interaction of inhibitory molecules LAG-3 and PD-1 in murine CD8+ T cell signaling Cancer Research
06/04/2012
Abstract 5397: The SOCS-1 derived peptides inhibit tumor development Cancer Research
06/04/2012
Abstract 5396: Interferon-{alpha} receptor dependent and independent inhibition of type I interferon production in plasmacytoid dendritic cells from mice and melanoma patients Cancer Research
06/04/2012
Abstract 5395: The E3 ligase Itch and deubiquitinase Cyld act together to regulate Tak1 and inflammation Cancer Research
06/04/2012
Abstract 5394: Tumor-induced immunological changes in peripheral blood of untreated stage IV non-squamous NSCLC patients Cancer Research
06/04/2012
Abstract 5392: Angiocidin induces differentiation of acute myeloid leukemia (AML) cells Cancer Research
06/04/2012
Abstract 5391: Antibody-drug conjugates in oncology drug development: Examining approaches to set the first-in-human dose Cancer Research
06/04/2012
Abstract 5389: 3M-011, a toll-like-receptor-7/8 agonist, as immunological adjuvans in combined therapy of gastrointestinal tumors Cancer Research
06/04/2012
Abstract 5388: Local mucosal CD8+T cell response is required to inhibit the growth of orthotopic head and neck and lung cancers Cancer Research
06/04/2012
Abstract 5387: Exploring effects of nanosecond and microsecond pulsed electric field ablation in a rat orthotopic hepatocellular carcinoma model Cancer Research
06/04/2012
Abstract 5386: Immunotherapy of bladder cancer using bacillus calmette guerin (BCG): Generation of cytotoxic T-cells is BCG strain dependent Cancer Research
06/04/2012
Abstract 5385: Effect of lenalidomide on antileukemia activity in vitro against adult T-cell leukemia (ATL) Cancer Research
06/04/2012
Abstract 5384: Frequency of gene allelic variants of the PAP prostate tumor antigen and association with immune response following antigen-specific genetic vaccination Cancer Research
06/04/2012
Abstract 5383: Evaluation of immune response in preclinical settings Cancer Research
06/04/2012
Abstract 5382: Vascular endotelial growth factor and transforming growth factor-beta are enhanced in plasma of breast cancer patients resistant to endocrine therapy Cancer Research
06/04/2012
Abstract 5381: Activation and frequency of myeloid subsets in peripheral blood is associated with clinical outcome in prostate cancer patients treated with Prostate GVAX and anti-CTLA4 Cancer Research
06/04/2012
Abstract 5380: Prophylactic MUC1/Poly-ICLC vaccine in individuals with the history of advanced colorectal adenoma Cancer Research
06/04/2012
Abstract 5379: Combination treatment with Bevacizumab, Lenalidomide, Docetaxel and Prednisone (ART-P) does not impact the immune response in patients with metastatic castration-resistant prostate cancer Cancer Research
06/04/2012
Abstract 5378: Phase I trial of EUS-guided intratumoral vaccination with recombinant Panvac-F and systemic Panvac-V in patients with locally advanced pancreatic cancer Cancer Research
06/04/2012
Abstract 5377: Low donor thymic output predicts increased incidence of extensive chronic GVHD and worse overall survival after TCD-matched sibling SCT Cancer Research
06/04/2012
Abstract 5376: Immunosuppressive T regs and MDSCs in human melanoma Cancer Research
06/04/2012
Abstract 5375: Modulation of circulating regulatory T-cells and MDSCs in high risk melanoma patients treated with neoadjuvant ipilimumab Cancer Research
06/04/2012
Abstract 5374: Significance of ADCC for the action of trastuzumab quantified by novel procedures Cancer Research
06/04/2012
Abstract 5373: Altering the composition of the proteasome of melanoma antigen RNA-transfected dendritic cells enhances vaccination-induced anti-melanoma immunity: results of a Phase I trial Cancer Research
06/04/2012
Abstract 5372: Dendritic-cell based vaccine for advanced pancreatic cancer: A report of 39 cases treated in Seren Clinic Nagoya Cancer Research
06/04/2012
Abstract 5371: Immune correlates of survival in advanced hepatocellular carcinoma patients treated with glypican-3-derived peptide vaccine: Results from phase I trial Cancer Research
06/04/2012
Abstract LB-136: IL-21-derived melanoma-reactive CTL combined with anti-CTLA4 persist, acquire central memory characteristics, and mediate tumor regression in patients with metastatic melanoma Cancer Research
06/04/2012
Abstract LB-135: A pilot study of peptide-based vaccines in combination with poly ICLC in patients with WHO grade 2 low-grade glioma Cancer Research
06/04/2012
Abstract LB-134: Personalized peptide vaccination as the second line therapy for patients with chemotherapy-resistant advanced pancreatic cancer. Cancer Research
06/04/2012
Abstract LB-133: Vaccination with dendritic cells pulsed with autologous oxidized whole tumor lysate induced strong and long-lasting anti-tumor immunity in recurrent ovarian cancer patients Cancer Research
06/04/2012
Abstract LB-132: The potential role of the multienzyme aminoacyl-tRNA synthetase complex in Th-1 immunity: implications for cancer immunotherapy Cancer Research
06/04/2012
Abstract LB-131: Peptide vaccine therapy for childhood gliomas: interim results of a pilot study Cancer Research
06/04/2012
Abstract LB-130: Immune reconstitution after chemotherapy correlates with increased in vitro immune response in breast cancer patients undergoing peptide vaccine therapy Cancer Research
06/04/2012
Abstract LB-129: CD8+ T cell response mediates the therapeutic effects of oncolytic adenovirus in an immunocompetent mouse model Cancer Research
06/04/2012
Abstract LB-128: Targeted RNAi screening of an EGFR network reveals molecular determinants of tumor cell sensitivity to antibody-dependent cellular cytotoxicity (ADCC) Cancer Research
06/04/2012
Abstract LB-127: Identifying an IDO-expressing "fibrocyte" subset of myeloid suppressor cells in pediatric cancer patients Cancer Research
06/04/2012
Abstract LB-126: Cancer-retina antigens as potential therapeutic targets for immunotherapy Cancer Research
06/04/2012
Abstract LB-124: Insulin growth factor-receptor (IGF-1R) antibody cixutumumab combined with the mTOR inhibitor temsirolimus in patients with refractory Ewing's sarcoma family tumors Cancer Research
06/04/2012
Abstract LB-123: Analyses of anti-cancer testis antigen antibodies in glioma patients treated with Delta-24 oncolytic adenovirus Cancer Research
06/04/2012
Abstract LB-122: A phase I dose escalation study of NVP-BGJ398, a selective pan FGFR inhibitor in genetically preselected advanced solid tumors Cancer Research
06/04/2012
Abstract LB-121: Randomized phase II study of the efficacy and safety of gemcitabine + TH-302 (G+T) vs gemcitabine (G) alone in previously untreated patients with advanced pancreatic cancer Cancer Research
06/04/2012
Abstract LB-120: Site of origin of basal cell carcinoma stromal cells Cancer Research
06/04/2012
Abstract LB-119: Therapeutic sensitivity and predictive markers for CDK4/6 inhibition defined by ex vivo analyses of human tumors Cancer Research
06/04/2012
Abstract LB-118: NC-001 induces apoptosis and necrosis in clear cell renal cell carcinoma in vitro and in a xenograft model in vivo Cancer Research
06/04/2012
Abstract LB-117: Phenotype and function of tumor-infiltrating macrophages and B cells in a novel humanized mouse model (NSG-HIS) for ovarian cancer Cancer Research
06/04/2012
Abstract LB-116: Immunodeficient pigs as a large animal model for human tumors Cancer Research
06/04/2012
Abstract LB-115: NAC1 is an actin binding protein essential for the cytokinesis of cancer cells and plays a role in the patterning of murine vertebral axis Cancer Research
06/04/2012
Abstract LB-114: Using molecular imaging to identify modulators of breast cancer metastasis Cancer Research
06/04/2012
Abstract LB-113: Non-invasive analysis of drug sensitivity in homo and-heterotypic multicellular tumor spheroids Cancer Research
06/04/2012
Abstract LB-112: Ex vivo lung cancer nodule model shows efficacy of nanoparticle delivery Cancer Research
06/04/2012
Abstract LB-111: Mastospheres as a new 3D ex vivo breast cancer microtumors for preclinical drug testing Cancer Research
06/04/2012
Abstract LB-110: Establishment of a chordoma xenograft and in vivo testing of compounds identified by high-throughput screening Cancer Research
06/04/2012
Abstract LB-109: MDV3100, an androgen receptor signaling inhibitor, inhibits tumor growth in breast cancer preclinical models regardless of estrogen receptor status Cancer Research
06/04/2012
Abstract LB-108: Racotumomab antitumor activity in the murine model of non small cell lung carcinoma 3LL is related with the level of expression on NGcGM3 Cancer Research
06/04/2012
Abstract LB-107: Aptitude for running in mice is age and strain-dependent but not predictive of tumor response Cancer Research
06/04/2012
Abstract LB-106: A novel TCL1-Tg:p53-/- mouse model of human CLL Cancer Research
06/04/2012
Abstract LB-105: Gli-IKBKE interactions in pancreatic tumorigenesis Cancer Research
06/04/2012
Abstract LB-104: Prostate-specific inactivation of Atbf1 causes mouse prostatic intraepithelial neoplasia Cancer Research
06/04/2012
Abstract LB-103: Conditional loss of ErbB3 delays mammary gland hyperplasias induced by mutant PIK3CA in transgenic mice, but does not affect mammary tumor latency, gene expression or signaling Cancer Research
06/04/2012
Abstract PL01-02: Human papillomavirus in the etiology and prevention of genital cancers Cancer Research
06/04/2012
Abstract LB-102: Role of HOX genes in regulation of stem cell populations in normal and malignant colon tissue Cancer Research
06/04/2012
Abstract SY01-01: Genetic and epigenetic mechanisms linking diet and bowel cancer Cancer Research
06/04/2012
Abstract PL01-01: The genetic basis for cancer therapeutics Cancer Research
06/04/2012
Abstract LB-101: Quantitative imaging of protein expression using multiplex quantum dot immunohistochemistry Cancer Research
06/04/2012
Abstract LB-100: Computational assessment of oncogenic pathways modulated by vorinostat in breast cancer stem cells Cancer Research
06/04/2012
Abstract LB-99: EGF receptor tyrosine kinase defines critical prognostic genes of stage IA lung adenocarcinoma Cancer Research
06/04/2012
Abstract LB-98: Transcriptomic and genomic landscape of ovarian cancer stem cells Cancer Research
06/04/2012
Abstract LB-97: Optimizing SELEX with high-throughput sequencing Cancer Research
06/04/2012
Abstract LB-96: Exploring personalized pathways enriched with putative cancer genes identified by next generation sequencing Cancer Research
06/04/2012
Abstract LB-95: Gene expression profiling of male breast cancer reveals two subgroups distinct from the intrinsic subtypes of female breast cancer Cancer Research
06/04/2012
Abstract LB-94: Highly specific and sensitive detection of BRAF and KRAS mutations in tumor samples Cancer Research
06/04/2012
Abstract LB-93: Demonstration of significant clonal evolution from diagnosis to relapse in childhood AML determined by exome capture sequencing: an NCI/COG TARGET AML study Cancer Research
06/04/2012
Abstract LB-91: Transcriptome analysis of esophageal squamous cell carcinoma by SAGE identifies a new biomarker, NRD1 Cancer Research
06/04/2012
Abstract LB-90: Essential kinases for human metastatic cells pertaining to c-Met signaling Cancer Research
06/04/2012
Abstract LB-89: Discovery and characterization of novel MTAP splice variants resulting in a hereditary form of osteosarcoma and demonstration of their dysregulation in sporadic forms of this cancer Cancer Research
06/04/2012
Abstract LB-88: Identification of recurrent oncogenic KIF5B-RET rearrangements in non-small cell lung cancer Cancer Research
06/04/2012
Abstract LB-87: Methylated-mediated repression of ZNF154 in ovarian cancer is associated with poor overall survival Cancer Research
06/04/2012
Abstract LB-86: Metabolic presentation of bladder cancer in urine Cancer Research
06/04/2012
Abstract LB-85: Ectopic expression of eukaryotic translation elongation factor eEF1A2 is a hallmark for human lung cancer and is associated with poor prognosis Cancer Research
06/04/2012
Abstract LB-84: The role of survivin and survivin variants in the mitotic arrest-induced cell death Cancer Research
06/04/2012
Abstract LB-83: Reduced expression of DRAM2 in tumor cells interferes with both apoptosis and autophagy Cancer Research
06/04/2012
Abstract LB-82: Modulation of autophagic flux by CPTH6, a Gcn5/pCAF histone acetyltransferase inhibitor with antitumoral activity Cancer Research
06/04/2012
Abstract LB-81: Autophagic degradation of BCR/ABL by arsenic trioxide and the role of cysteine cathepsins Cancer Research
06/04/2012
Abstract LB-80: Role of ER calcium in Bcl-2 resistance to dosage and duration-related cytotoxic efficacy of Taxol Cancer Research
06/04/2012
Abstract LB-79: Synergistic anticancer effects of the 9.2.27PE immunotoxin and ABT-737 in melanoma involves silencing of the anti-apoptotic protein Mcl-1 Cancer Research
06/04/2012
Abstract LB-78: Synergistic effect of combination of MEK and phosphatidylinositol 3-kinase inhibitor on cell death in human prostate cancer DU145 cells Cancer Research
06/04/2012
Abstract LB-77: Crm1-mediated nucleocytoplasmic transport inhibition perturbs multiple cellular pathways to trigger melanoma cell apoptosis Cancer Research
06/04/2012
Abstract LB-76: Mibefradil, a novel therapy for glioblastoma: An interlaced therapy approach Cancer Research
06/04/2012
Abstract LB-75: Glucocorticoid receptor activation inhibits p53-induced apoptosis of MCF10A myc cells via induction of protein kinase C epsilon Cancer Research
06/04/2012
Abstract LB-74: The estrogen receptor regulates the transcription of p53 target genes in breast cancer cells Cancer Research
06/04/2012
Abstract LB-72: A20 ubiquitin ligase-mediated RIP1 polyubiquitin chains inhibits TRAIL-induced apoptosis in glioblastoma Cancer Research
06/04/2012
Abstract LB-69: Role of HDAC1 in epigenetic repression of E-cadherin after transient Epstein Barr virus infection Cancer Research
06/04/2012
Abstract LB-68: Mouse mammary tumor virus suppress apoptosis through Src signaling in the mammary epithelial cells Cancer Research
06/04/2012
Abstract LB-67: COX-2/PGE2: molecular ambassadors of Kaposi's sarcoma associated herpes virus (KSHV) oncoprotein-v-FLIP Cancer Research
06/04/2012
Abstract LB-66: Oncogenic properties of tax protein from human T cell leukemia virus type 2 Cancer Research
06/04/2012
Abstract LB-65: Protein kinase C{varepsilon}, which is linked to development of squamous cell carcinomas, potentiates ultraviolet radiation-induced expression of novel transcription factors GATA and PAX, which regulates expression of cell survival genes Cancer Research
06/04/2012
Abstract LB-64: Selective estrogen receptor modulators (SERMs) act as breast cancer chemopreventive agents by attenuating oxidative estrogen metabolism Cancer Research
06/04/2012
Abstract LB-63: (S)-N'-nitrosonornicotine, a constituent of smokeless tobacco, is a potent oral tumorigen in rats Cancer Research
06/04/2012
Abstract LB-61: Targeting cancer cell metabolism in pancreatic cancer: p53, a key regulator of glycolysis and a major factor deciding the outcome of targeting the Warburg effect Cancer Research
06/04/2012
Abstract LB-60: Long-term use of hormone therapy and breast cancer incidence and mortality Cancer Research
06/04/2012
Abstract LB-59: Progressing Forward in Timely Fashion Cancer Research
06/04/2012
Abstract LB-58: Advocacy within the PS-OC: Evolution of the program Cancer Research
06/04/2012
Abstract LB-57: Susan G. Komen for the Cure- A global breast cancer movement Cancer Research
06/04/2012
Abstract LB-56: My journey as a breast cancer survivor, from diagnosis to advocate Cancer Research
06/04/2012
Abstract LB-55: The European Cancer Patient Coalition speaks with a single voice for all cancer patients Cancer Research
06/04/2012
Abstract LB-54: The foundation for melanoma research Cancer Research
06/04/2012
Abstract LB-53: Cancer clinical trials: real answers, real options, real miracles, right here in west Michigan Cancer Research
06/04/2012
Abstract LB-52: Relentless in the fight against blood cancer: the Leukemia & Lymphoma Society Cancer Research
06/04/2012
Abstract LB-51: Breast cancer survivorship in women younger than 45 years Cancer Research
06/04/2012
Abstract LB-50: Street smarts: cancer education and outreach in the homeless community Cancer Research
06/04/2012
Abstract LB-245: Investigating the role of BRCA1 in sensitivity to GRN163L, a telomerase template antagonist Cancer Research
06/04/2012
Abstract LB-244: BAY 87-2243, an inhibitor of HIF-1{alpha} - induced gene activation, showed promising anti-tumor efficacy in combination with anti-angiogenic therapy and irradiation in preclinical tumor models Cancer Research
06/04/2012
Abstract LB-243: Cetuximab and Artesunate synergistically inhibit the invasion and distant metastasis of non-small cell lung cancer Cancer Research
06/04/2012
Abstract LB-242: Mammalian orthoreovirus downregulates HIF-1{alpha} in hypoxic prostate tumor cells via RACK1-mediated proteasomal degradation and translational inhibition Cancer Research
06/04/2012
Abstract LB-241: Targeting cancer cells and anti-tumor effects of brucine immuno-nanoparticles on hepatocellular carcinoma in vivo Cancer Research
06/04/2012
Abstract LB-240: Mechanism-based enhancement of ErbB2-targeted delivery of chemotherapeutics encapsulated in Trastuzumab-conjugated polymeric nanocarriers Cancer Research
06/04/2012
Abstract LB-239: ROCK1 inhibition reduces tumor collagen content in the KPC model for PDAC Cancer Research
06/04/2012
Abstract LB-237: In vitro and in vivo characterization of CPI-267203, a potent Inhibitor of bromodomain-containing proteins Cancer Research
06/04/2012
Abstract LB-236: M4-3-ML2, a novel glycoengineered humanized IgG1 antibody, targeting a membrane-proximal epitope of MCSP/CSPG4 exhibits potent ADCC induction in vitro and in vivo anti-tumoral efficacy in disseminated melanoma models Cancer Research
06/04/2012
Abstract LB-235: Sensitivity of diffuse large B cell lymphoma cells to Enzastaurin (LY317615.HCl) and its primary metabolite (LY326020) is critically dependent upon disruption of the eIF4F translation initiation complex Cancer Research
06/04/2012
Abstract LB-233: Immune-related efficacy data of the phase 1-2 study of an with fourfold gene-modified allogeneic tumor cell based vaccine in patients with advanced renal cell carcinoma Cancer Research
06/04/2012
Abstract LB-232: Preliminary results of a phase I study of the novel CRM1 inhibitors KPT-276 and KPT-335 in dogs with spontaneous cancer Cancer Research
06/04/2012
Abstract LB-231: Phase Ib dose escalation and biomarker study of MK2206 in combination with standard doses of weekly paclitaxel in patients with locally advanced or metastatic solid tumors with expansion in advanced breast cancer Cancer Research
06/04/2012
Abstract LB-230: A prospective clinical trial to evaluate DNA sequencing as a diagnostic tool to guide cancer therapy: results from the initial 50 patients Cancer Research
06/04/2012
Abstract LB-229: Treatment of advanced cancer patients with a newest poly-epitope peptide vaccine to the thymidylate synthase(TSPP): a phase Ib (TSPP/VAC1) trial Cancer Research
06/04/2012
Abstract LB-228: Association of XRCC1 SNPs with clinical response in AML patients Cancer Research
06/04/2012
Abstract LB-227: Pilot clinical trials of FSPG (BAY 94-9392): An 18F-labeled glutamate derivative for PET imaging of system xC- activity in tumors Cancer Research
06/04/2012
Abstract LB-226: mTOR inhibition by Temsirolimus as second-line treatment for advanced RCC: The Medical optimization of Torisel(R) (MoTOR) phase II trial by the Italian Kidney Cancer Group (GIR) Cancer Research
06/04/2012
Abstract LB-225: Phase 2 Trial of nab-paclitaxel plus carboplatin for advanced NSCLC in patients at risk of bleeding from VEGF directed therapies Cancer Research
06/04/2012
Abstract LB-224: A randomized phase 2 study of two doses of itraconazole in men with metastatic castration-resistant prostate cancer (mCRPC) Cancer Research
06/04/2012
Abstract LB-223: An open-label, exploratory phase II study of oral itraconazole for the treatment of basal cell carcinoma Cancer Research
06/04/2012
Abstract LB-222: Lapatinib has antiproliferative effects in both HER2 positive (+) and HER2 negative (-) breast cancer (BC): results from the MAPLE short-term pre-surgical trial (CRUK E/06/039) Cancer Research
06/04/2012
Abstract LB-221: Phase II study of therapy selected by molecular profiling in patients with previously treated metastatic pancreatic cancer. A study of the stand up to cancer (SU2C) consortium Cancer Research
06/04/2012
Abstract LB-220: Translational research with RG7160 (GA201) leads to a phase II clinical study in combination with FOLFIRI in 2nd line metastatic colorectal cancer (mCRC) Cancer Research
06/04/2012
Abstract LB-219: Neoadjuvant multidisciplinary phase II study (BRANCH) of an early bevacizumab schedule plus chemo-radiation therapy in rectal cancer: efficacy, safety, and biomarkers. Cancer Research
06/04/2012
Abstract LB-218: Immune response assessment in a phase II trial of AE37 HER2 peptide vaccine Cancer Research
06/04/2012
Abstract LB-217: Lycopene and gene expression in benign prostate: a phase II randomized trial Cancer Research
06/04/2012
Abstract LB-216: Receptor targeted (CD206) Tc99m tilmanocept localization in sentinel nodes in breast cancer and melanoma is concordant with preoperative imaging and a reduction in missed disease Cancer Research
06/04/2012
Abstract LB-214: Interim results from a randomized Phase 1-2 first-in-human (FIH) study of PK/PD guided escalating doses of SGI-110, a novel subcutaneous (SQ) second generation hypomethylating agent (HMA) in relapsed/refractory MDS and AML Cancer Research
06/04/2012
Abstract LB-212: Ionizing radiation selectively promotes invasion of ErbB2-expressing breast cancer cells via regulation of FoxM1 Cancer Research
06/04/2012
Abstract LB-211: beta1 integrin targeting results in radiosensitization by controlling DNA repair mechanisms and chromatin organization Cancer Research
06/04/2012
Abstract LB-210: Abrogation of mutant TP53 radiation resistance by lithium induced CTNNB1 ({beta}-catenin) activation in medulloblastoma. Cancer Research
06/04/2012
Abstract LB-209: Identification and characterization of small molecule inhibitor of Wnt canonical pathway in a glioma setting. Cancer Research
06/04/2012
Abstract LB-208: Notch2 in vivo genetic labeling reveals novel epithelial subtypes within mammary luminal lineage Cancer Research
06/04/2012
Abstract LB-207: Tissue transglutaminase (TG2) - the key driver in inflammation-induced progression of cancer Cancer Research
06/04/2012
Abstract LB-206: A new platform for diagnosis and therapeutic targeting of cancer stem cells Cancer Research
06/04/2012
Abstract LB-205: Identification of tumorigenic cells in KrasG12D-induced lung adenocarcinoma Cancer Research
06/04/2012
Abstract LB-204: Matrix metalloproteinase-10 is required for lung cancer stem cell maintenance, tumor initiation and metastatic potential Cancer Research
06/04/2012
Abstract SY02-03: Bromodomain inhibition in cancer Cancer Research
06/04/2012
Abstract PL02-03: Genomic mapping of cancer origins Cancer Research
06/04/2012
Abstract LB-203: Mathematical modeling of the dynamic interaction between cancers stem cells and non-stem cancer cells and its potential clinical implication Cancer Research
06/04/2012
Abstract SY02-02: Inhibition of methyltransferase EZH2 Cancer Research
06/04/2012
Abstract PL02-02: Lgr5 ctem cells in self-renewal and cancer Cancer Research
06/04/2012
Abstract LB-202: The significance of stress-responsive molecules in cancer stem cells derived from ovarian and endometrial cancer Cancer Research
06/04/2012
Abstract SY02-01: Targeting the histone methyltransferase DOT1L in MLL-rearranged leukemia Cancer Research
06/04/2012
Abstract PL02-01: Normalizing the tumor microenvironment to enhance therapeutic outcome Cancer Research
06/04/2012
Abstract LB-201: Prostate cancer stem cells display low mTOR activity and resistance to mTOR inhibitors in hypoxia Cancer Research
06/04/2012
Abstract LB-200: IL-1beta promotes the development of intestinal epithelial stem cells Cancer Research
06/04/2012
Abstract LB-199: ZEB factors link IL-1{beta}-induced EMT and stem cell phenotypes in colon cancer Cancer Research
06/04/2012
Abstract LB-198: Ryl hydrocarbon receptor agonist Aminoflavone disrupts mammosphere formation via alpha 6 integrin inhibition Cancer Research
06/04/2012
Abstract LB-197: An alternative splicing signature that identifies breast cancer stem cells Cancer Research
06/04/2012
Abstract LB-196: Anti-DLL4 reduces tumor growth and tumorigenicity in B-RAF V600E melanomas including those with acquired resistance to B-RAF inhibitors Cancer Research
06/04/2012
Abstract LB-195: Immune responses against cancer stem cell-specific tumor antigens and tumor microenvironment Cancer Research
06/04/2012
Abstract LB-194: The Wnt inhibitor VS-507 reduces cancer stem cell (CSC) function in vitro and tumorigenicity in mice Cancer Research
06/04/2012
Abstract LB-193: Ganglioside GD2 identifies cancer stem cells and inhibition of GD2 biosynthesis by targeting GD3 synthase exerts antitumor effects Cancer Research
06/04/2012
Abstract LB-192: The FAK inhibitors VS-4718 and VS-5095 attenuate breast cancer stem cell function in vitro and tumor growth in vivo Cancer Research
06/04/2012
Abstract LB-191: Glioblastomas can originate from neurons in the CNS Cancer Research
06/04/2012
Abstract LB-190: Growth hormone signaling in mammary stem and progenitor cells Cancer Research
06/04/2012
Abstract LB-189: A role of Notch2 in quiescence of mammary stem/progenitor cells Cancer Research
06/04/2012
Abstract LB-187: Modulation of redox status: An alternative approach for prevention and treatment of prostate cancer Cancer Research
06/04/2012
Abstract LB-186: Differential effects of stress on tumor initiation and progression - role of neuropeptide Y Cancer Research
06/04/2012
Abstract LB-185: Cytokinesis-blocked micronuclei Assay (CBMN) as a biological cancer risk assessment tool Cancer Research
06/04/2012
Abstract LB-184: Differential effects of sulforaphane and related isothiocyanates on HDAC turnover and the DNA damage response in colon cancer cells Cancer Research
06/04/2012
Abstract LB-183: Identification of anti-cancer activity in structural components of ancestral wheat Cancer Research
06/04/2012
Abstract LB-182: Effects of methyl donor status on intestinal tumorigenesis in ApcMin/+ mice Cancer Research
06/04/2012
Abstract LB-181: Piperlongumine inhibits growth and survival of human Burkitt lymphoma by downregulating NF-{kappa}B, c-Myc and LMP1 Cancer Research
06/04/2012
Abstract LB-180: Notch-1: A therapeutic target for breast cancer stem cells and breast cancer cells Cancer Research
06/04/2012
Abstract LB-179: Effect of silibinin on the growth kinetics of 3D tumor spheroids: Colorectal cancer cells enriched for cancer stem cell phenotype Cancer Research
06/04/2012
Abstract LB-178: A novel chemopreventive molecular mechanism of selenium: p53-mediated DNA repair Cancer Research
06/04/2012
Abstract LB-177: A supercritical turmeric extract prevents small intestinal and colonic tumors in the APCMin/+ mice by suppressing proliferation and cancer stem cell markers Cancer Research
06/04/2012
Abstract LB-176: Chemoprevention of NNK-induced lung adenoma and adenocarcinoma in A/J mice by p53 modulating agents, CP-31398 and Prima-1 Cancer Research
06/04/2012
Abstract LB-175: {beta}-Escin inhibits NNK-induced lung adenocarcinoma formation in A/J mice by suppressing ALDH1A1 positive cells; and RhoA/Rock induced invasion of human lung cancer cell growth. Cancer Research
06/04/2012
Abstract LB-174: Enhanced prostate tumorigenesis in TgAPT121 mice lacking prostatic VDR expression Cancer Research
06/04/2012
Abstract LB-173: Maraviroc, a CCR5 antagonist, prevents development of hepatocellular carcinoma in a mouse model Cancer Research
06/04/2012
Abstract LB-172: MicroRNAs mediate the inhibition of tumor cell invasion by sulindac Cancer Research
06/04/2012
Abstract LB-171: Dietary agent induced AMPK activation: Targeting stem cells for the prevention of colon cancer Cancer Research
06/04/2012
Abstract LB-170: A role of sphingosine kinase 1 in peritoneal macrophages on the early stages of colon carcinogenesis Cancer Research
06/04/2012
Abstract LB-169: Metformin reduces somatic cell mutation rate by inhibiting mitochondrial ROS production: relevance to cancer prevention Cancer Research
06/04/2012
Abstract LB-168: A hexane fraction of American ginseng suppresses colon cancer associated with colitis Cancer Research
06/04/2012
Abstract LB-167: Prepubertal or lifetime genistein intake reduces risk of tamoxifen resistance in rats Cancer Research
06/04/2012
Abstract LB-165: The role of sphingolipid metabolism in the treatment of acute myeloid leukemia Cancer Research
06/04/2012
Abstract LB-164: IDH mutations and tumorgenicity Cancer Research
06/04/2012
Abstract LB-163: Modulation of glucose metabolism by CD44 contributes to antioxidant status and drug resistance in cancer cells Cancer Research
06/04/2012
Abstract LB-162: DNA-damage foci persistence and accelerated senescence as determinants of radiosensitization by glycolysis inhibitors Cancer Research
06/04/2012
Abstract LB-161: Metformin increases lipolytic metabolism and PEDF expression in prostate cancer cells Cancer Research
06/04/2012
Abstract LB-160: CYP4F isoform expression and 20-HETE synthesis in prostate cancer cells are regulated by androgen and contribute to growth Cancer Research
06/04/2012
Abstract LB-159: Using proton MRSI to predict response of Vorinostat treatment in recurrent GBM Cancer Research
06/04/2012
Abstract LB-158: STAT5 regulates mitochondrial gene expression through direct binding to mitochondrial DNA Cancer Research
06/04/2012
Abstract LB-157: Combined treatment with clarithromycin and bortezomib enhances cytotoxicity via endplasmic reticulum stress-meidated CHOP induction and autophagy in breast cancer cells Cancer Research
06/04/2012
Abstract LB-156: The role of AKR1B10 in early tumorigenesis depends on AMP-activated protein Kinase-{alpha} checkpoint Cancer Research
06/04/2012
Abstract LB-155: Smad4 negatively regulates beta-catenin signaling through proteasomal degradation of Aurora A in human cancer cells Cancer Research
06/04/2012
Abstract LB-154: Nuclear export of CALM-AF10 is essential for leukemogenesis Cancer Research
06/04/2012
Abstract LB-153: The helicase antigen (HAGE) promotes tumor cell proliferation via up-regulation of Ras protein signalling. Cancer Research
06/04/2012
Abstract LB-152: PIK3CA mutation spectrum in urothelial carcinoma reflects cell context-dependent signalling and phenotypic outputs Cancer Research
06/04/2012
Abstract LB-151: Spred1 and neurofibromin interact to negatively regulate Ras/Raf/MEK/ERK signaling Cancer Research
06/04/2012
Abstract LB-150: Binding selectivity of RNAs by eukaryotic initiation factor 3f in pancreatic cells Cancer Research
06/04/2012
Abstract LB-149: The OPCML tumor suppressor binds and negatively regulates the Axl receptor tyrosine kinase, sensitizing cells to foretinib in epithelial ovarian cancer (EOC) Cancer Research
06/04/2012
Abstract LB-148: The role of EZH2 in the regulation of the activity of matrix metalloproteinases in prostate cancer cells Cancer Research
06/04/2012
Abstract LB-147: PXR inhibits PC3 tumor growth through regulation of HIF-1 expression Cancer Research
06/04/2012
Abstract LB-146: A study of p16 inactivation in lung cancer cell lines and tumor samples with a meta-analysis of the literature Cancer Research
06/04/2012
Abstract LB-145: Folliculin interacts with p0071 (Plakophilin-4) and deficiency is associated with disordered RhoA signalling, epithelial polarization and cytokinesis Cancer Research
06/04/2012
Abstract LB-144: A p53-dependent G2/M checkpoint governed by the cell-fate factor dachshund in non-small cell lung cancer Cancer Research
06/04/2012
Abstract LB-143: ErbB2, EphrinB1, Src kinase and PTPN13 signaling complex regulates MAP kinase signaling in human cancers Cancer Research
06/04/2012
Abstract LB-142: Induced expression and activation of oncogenes in NSCLC (non-small cell lung cancer) in the absence of activating mutations of EGFR and k-Ras Cancer Research
06/04/2012
Abstract LB-140: Targeting brain tumour initiating cells using a dual-pronged approach of oncolytic virotherapy and chemotherapeutics Cancer Research
06/04/2012
Abstract LB-139: In situ Treg immunomodulation at a single tumor site with CpG and immune checkpoint antibodies cures metastatic disease Cancer Research
06/04/2012
Abstract LB-138: Stimulation of natural killer cells with an anti-CD137 antibody enhances the efficacy trastuzumab, cetuximab, and rituximab in HER2-expressing breast cancer, EGFR+ head and neck cancer, and CD20+ lymphoma Cancer Research
06/04/2012
Abstract LB-137: A new clinical-grade MEMS-based cell sorter for adoptive T-cell therapy Cancer Research